Document:

<PAGE>

                                                                   Exhibit 10.11

                                EMAGEON UV, INC.
                         SECOND AMENDMENT AND JOINDER TO
               AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

      THIS SECOND AMENDMENT AND JOINDER ("Second Amendment") to the Amended and
Restated Registration Rights Agreement of Emageon UV, Inc., dated October 2,
2001, as amended by the First Amendment and Joinder to the Amended and Restated
Registration Rights Agreement, dated May 30, 2003 (collectively, the
"Agreement"), is made as of June 25, 2003, by and among EMAGEON UV, INC., a
Delaware corporation (the "Company"), those holders of the Company's Series A
Preferred Stock, Series B Preferred Stock, Series B-1 Preferred Stock, Series C
Preferred Stock and Series D Preferred Stock that are parties to the Agreement,
Charles A. Jett, Jr., Gary A. York, and the undersigned parties holding all of
the Company's outstanding shares of Series E Preferred Stock. Capitalized terms
used herein but not otherwise defined shall have the meanings given to such
terms in the Agreement.

                                   WITNESSETH:

      WHEREAS, the Series A Holders, Series B Holders, Series B-1 Holders,
Series C Holders, Series D Holders, Jett and York (collectively, the "Existing
Parties") are parties to the Agreement;

      WHEREAS, the Company and the Series E Holders have entered into a Series E
Preferred Stock Purchase Agreement of even date herewith pursuant to which the
Company desires to sell to the Series E Holders and the Series E Holders desire
to purchase from the Company shares of the Company's Series E Preferred Stock;

      WHEREAS, a condition to the Series E Holders' obligations under the Series
E Preferred Stock Purchase Agreement is that the Company, the Existing Parties
and the Series E Holders become parties to the Agreement in order to provide the
Series E Holders with certain rights to register shares of the Company's Common
Stock issuable upon conversion of the Series E Preferred Stock held by the
Series E Holders;

      WHEREAS, Section 12 of the Agreement provides that the Company shall not
grant demand registration rights to any party or any incidental registration
rights that are superior to or pari passu with the incidental registration
rights of the Investor Holders without the written consent of Investor Holders
representing in the aggregate more than 50% of the Registrable Shares then held
by such Investor Holders;

      WHEREAS, pursuant to Section 13 of the Agreement, any term of the
Agreement may be amended with the written consent of the Company and Holders
representing in the aggregate more than 50% of the Registrable Shares, and any
amendment effected in accordance with Section 13 of the Agreement shall be
binding upon each Holder, each future Holder and the Company;

<PAGE>

      WHEREAS, the Company desires to amend the Agreement;

      WHEREAS, (i) the undersigned Investor Holders, which hold more than 50% of
the Registrable Shares held by Investor Holders, and (ii) the undersigned
Existing Parties, which hold more than 50% of the Registrable Shares, desire to
amend the Agreement to extend to the holders of the Company's Series E Preferred
Stock the rights and obligations of a Holder under the Agreement; and

      WHEREAS, the undersigned holders of all of the outstanding shares of the
Company's Series E Preferred Stock desire to become parties to the Agreement, as
amended by this Second Amendment.

      NOW, THEREFORE, in consideration of the premises and the mutual terms and
conditions set forth herein, it is hereby agreed by and among the Company, the
Series A Holders, Series B Holders, Series B-1 Holders, Series C Holders, Series
D Holders, Jett and York that the Agreement is hereby amended in accordance with
this Second Amendment, and the undersigned holders of all of the outstanding
shares of the Company's Series E Preferred Stock shall become parties to the
Agreement, as amended by this Second Amendment:

1.    AMENDMENTS.

      (a)   The initial paragraph of the Agreement is hereby deleted in its
entirety and replaced with the following:

      "This Amended and Restated Registration Rights Agreement (the "AGREEMENT")
      is made and entered into as of October 2, 2001, by and among Emageon UV,
      Inc., a Delaware corporation (the "COMPANY"), those holders of the Series
      A Preferred Stock of the Company listed on Schedule 1 attached hereto and
      made a part hereof (each, a "SERIES A HOLDER" and collectively, the
      "SERIES A HOLDERS"), those holders of the Series B Preferred Stock of the
      Company listed on Schedule 2 attached hereto and made a part hereof (each,
      a "SERIES B HOLDER" and collectively the "SERIES B HOLDERS"), those
      holders of the Series B-1 Preferred Stock of the Company listed on
      Schedule 3 attached hereto and made a part hereof (each, a "SERIES B-1
      HOLDER" and collectively, the "SERIES B-1 HOLDERS"), those holders of the
      Series C Preferred Stock of the Company listed on Schedule 4 attached
      hereto and made a part hereof (each a "SERIES C HOLDER" and collectively
      the "SERIES C HOLDERS"), those holders of the Series D Preferred Stock of
      the Company listed on Schedule 5 attached hereto and made a part hereof
      (each a "SERIES D HOLDER" and collectively the "SERIES D HOLDERS"), those
      holders of the Series E Preferred Stock of the Company listed on Schedule
      6 attached hereto and made a part hereof (each a "SERIES E HOLDER" and
      collectively the "SERIES E HOLDERS"), Charles A. Jett, Jr. ("JETT") and
      Gary A. York ("YORK")

<PAGE>

      (each of Jett and York, a "FOUNDER," and collectively, the "FOUNDERS")."

      (b)   The definition of Preferred Stock in Section 1 of the Agreement is
hereby deleted in its entirety and replaced with the following:

      "`Preferred Stock'" means the Series A Preferred Stock of the Company,
      $0.001 par value per share, the Series B Preferred Stock of the Company,
      $0.001 par value per share, the Series B-1 Preferred Stock of the Company,
      $.001 par value per share, the Series C Preferred Stock of the Company,
      $0.001 par value per share, the Series D Preferred Stock of the Company,
      $0.001 par value per share, and the Series E Preferred Stock of the
      Company, $0.001 par value per share."

      (c)   The last sentence of Section 13 is hereby deleted in its entirety
and replaced with the following:

      "Notwithstanding anything to the contrary in this Section 13, the Company
      shall be entitled to add additional purchasers of Series E Preferred Stock
      pursuant to Section 2.1 of the Series E Preferred Stock Purchase
      Agreement, dated as of June 25, 2003, as parties to this Agreement as and
      in the manner set forth in such Section 2.1, and each such additional
      purchaser shall thereafter be deemed to be an Investor Holder for all
      purposes hereunder."

      (d)   A new Schedule 6 is hereby added to the Agreement in the form
attached as EXHIBIT A hereto.

2.    JOINDER. Each undersigned holder of shares of the Company's Series E
Preferred Stock hereby agrees that upon execution of this Second Amendment by
such person or entity, such person or entity shall become a party to the
Agreement, as amended by this Second Amendment, and shall be fully bound by, and
subject to, all of the covenants, terms and conditions of the Agreement, as
amended by this Second Amendment, as though such person or entity were an
original party thereto and shall be deemed a Holder for all purposes thereof.

3.    GENERAL PROVISIONS.

      (a)   NO OTHER AMENDMENTS. Except for the amendments contained in SECTION
1 of this Second Amendment, the Agreement shall remain in full force and effect.

      (b)   AUTHORIZATION. Each Holder (which term shall include the undersigned
holders of shares of the Company's Series E Preferred Stock) hereby represents
and warrants to the Company and to each other that (i) such Holder has full
power and authority to execute, to deliver and to perform such Holder's
obligations under this Second Amendment; and (ii) the execution and delivery of
this Second Amendment has

<PAGE>

been duly and validly authorized, and all necessary action has been taken to
make this Second Amendment a valid and binding obligation of such Holder,
enforceable in accordance with its terms, except that the enforcement thereof
may be subject to bankruptcy, insolvency, reorganization, moratorium or other
similar laws now or hereafter in effect relating to creditors' rights generally
and to general principles of equity (regardless of whether such enforcement is
considered a proceeding in equity or at law).

      (c)   GOVERNING LAW. This Second Amendment shall be governed by and
construed under the laws of the State of Delaware, as applied to agreements
among Delaware residents made and to be performed entirely within the State of
Delaware, and without regard to the conflicts of law principles as may otherwise
be applicable.

      (d)   BINDING ON SUCCESSORS. This Second Amendment shall bind and inure to
the benefit of the parties hereto, their respective heirs, executors,
administrators, successors and permitted assigns.

      (e)   COUNTERPARTS AND SIGNATURE BY FACSIMILE. This Second Amendment may
be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same
instrument. The facsimile signature of any party to this Second Amendment for
purposes of execution or otherwise is to be considered as an original signature,
and the document transmitted is to be considered to have the same binding effect
as an original signature on an original document. At the request of any party,
any facsimile or telecopy document is to be re-executed in original form by the
parties who executed the facsimile or telecopy document. No party may raise the
use of a facsimile machine or telecopier or the fact that any signature was
transmitted through the use of a facsimile or telecopier machine as a defense to
the enforcement of this Second Amendment or any notice required thereof.

                   [THE FOLLOWING PAGE IS THE SIGNATURE PAGE]

<PAGE>

                                    EXHIBIT A

                                   SCHEDULE 6

                                SERIES E HOLDERS

ASCENSION HEALTH
CB HEALTHCARE FUND II, L.P.
CB-AH PARALLEL FUND II, L.P.
SOUTHEASTERN TECHNOLOGY FUND, L.P.
STF PARTNERS II, L.P.
STF PARTNERS QP II, L.P.
STF INSTITUTIONAL PARTNERS II, L.P.
THE PERMANENTE FEDERATION LLC
KAISER FOUNDATION HOSPITALS
HARBINGER/AURORA VENTURE FUND, L.L.C.
HARBINGER/AURORA QP VENTURE FUND, L.L.C.
JOHN W. THOMPSON
R. RYAN KUBLY
TIM REILAND
JOHN C. THOMPSON
GREGORY LYNCH & EILEEN SCHNABEL
DENNIS SKOGEN
ROLAND REINHOLTZ
GFP ULTRAVISUAL LLC
MICHAEL G. LASKIS
JEFF RUSINOW
WHITT CASE
MEHTA REVOCABLE TRUST
MARCUS COHEN, M.D.
HARRY ROTH
JAMES RIEDERER
ANTHONY J. JASEN
WILLIAM J. KALMER CLU LTD.
JOHN A. TURCOTT
DAVE REINECKE
TERENCE F. KELLY
JAMES E. BURGESS
PHILIP F. POWONDRA
HERMAN AND GWEN SHAPIRO FOUNDATION
DAVID G. WALSH
JAMES J. SILBERNAGEL AND JOANNE M. SILBERNAGEL FAMILY TRUST
WILLIAM D. MELTON
RICHGOOD CORPORATION
GREYSTONE CAPITAL PARTNERS I, LLC

<PAGE>

JEMISON INVESTMENT CO., INC.
JAMES D. DAVIS
MILLER INVESTMENT LLC

<PAGE>

                                  EMAGEON, INC.
                         FIRST AMENDMENT AND JOINDER TO
               AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

      THIS FIRST AMENDMENT AND JOINDER ("Amendment") to the Amended and Restated
Registration Rights Agreement of Emageon, Inc., dated October 2, 2001 (the
"Agreement"), is made as of May 30, 2003, by and among EMAGEON, INC., a Delaware
corporation (the "Company"), those holders of the Company's Series A Preferred
Stock, Series B Preferred Stock, Series B-1 Preferred Stock, and Series C
Preferred Stock parties to the Agreement, Charles A. Jett, Jr., Gary A. York,
and the undersigned parties holding all of the Company's outstanding shares of
Series D Preferred Stock. Capitalized terms used herein but not otherwise
defined shall have the meanings given to such terms in the Agreement.

                                   WITNESSETH:

      WHEREAS, the Series A Holders, Series B Holders, Series B-1 Holders,
Series C Holders, Jett, and York (collectively, the "Existing Parties") are
parties to the Agreement;

      WHEREAS, Section 12 of the Agreement provides that the Company shall not
grant demand registration rights to any party or any incidental registration
rights that are superior to or pari passu with the incidental registration
rights of the Investor Holders without the written consent of Investor Holders
representing in the aggregate more than 50% of the Registrable Shares then held
by such Investor Holders;

      WHEREAS, pursuant to Section 13 of the Agreement, any term of the
Agreement may be amended with the written consent of the Company and Holders
representing in the aggregate more than 50% of the Registrable Shares, and any
amendment effected in accordance with such Section 13 of the Agreement shall be
binding upon each Holder, each future Holder and the Company;

      WHEREAS, the Company desires to amend the Agreement;

      WHEREAS, (i) the undersigned Investor Holders, which hold more than 50% of
the Registrable Shares held by Investor Holders, and (ii) the undersigned
Existing Parties, which hold more than 50% of the Registrable Shares, desire to
amend the Agreement to extend to the holders of the Company's Series D Preferred
Stock the rights and obligations of a Holder under the Agreement; and

      WHEREAS, the undersigned holders of all of the outstanding shares of the
Company's Series D Preferred Stock desire to become parties to the Agreement, as
amended by this Amendment.

      NOW, THEREFORE, in consideration of the premises, and the mutual terms and
conditions set forth herein, it is hereby agreed by and among the Company, the
Series A Holders, Series B Holders, Series B-1 Holders, Series C Holders, Jett
and York that the Agreement is hereby amended in accordance with this Amendment,
and the undersigned

<PAGE>

holders of all of the outstanding shares of the Company's Series D Preferred
Stock shall become parties to the Agreement, as amended by this Amendment:

1.    AMENDMENTS.

      (a)   The initial paragraph of the Agreement is hereby deleted in its
entirety and replaced with the following:

      "This Amended and Restated Registration Rights Agreement (the "AGREEMENT")
      is made and entered into as of October 2, 2001, by and among Emageon,
      Inc., a Delaware corporation (the "COMPANY"), those holders of the Series
      A Preferred Stock of the Company listed on Schedule 1 attached hereto and
      made a part hereof (each, a "SERIES A HOLDER" and collectively, the
      "SERIES A HOLDERS"), those holders of the Series B Preferred Stock of the
      Company listed on Schedule 2 attached hereto and made a part hereof (each,
      a "SERIES B HOLDER" and collectively the "SERIES B HOLDERS"), those
      holders of the Series B-1 Preferred Stock of the Company listed on
      Schedule 3 attached hereto and made a part hereof (each, a "SERIES B-1
      HOLDER" and collectively, the "SERIES B-1 HOLDERS"), those holders of the
      Series C Preferred Stock of the Company listed on Schedule 4 attached
      hereto and made a part hereof (each a "SERIES C HOLDER" and collectively
      the "SERIES C HOLDERS"), those holders of the Series D Preferred Stock of
      the Company listed on Schedule 5 attached hereto and made a part hereof
      (each a "SERIES D HOLDER" and collectively the "SERIES D HOLDERS"),
      Charles A. Jett, Jr. ("JETT"), and Gary A. York ("YORK") (each of Jett and
      York, a "FOUNDER," and collectively, the "FOUNDERS")."

      (b)   The definition of Preferred Stock in Section 1 of the Agreement is
hereby deleted and replaced with the following:

      "`Preferred Stock'" means the Series A Preferred Stock of the Company,
      $0.001 par value per share, the Series B Preferred Stock of the Company,
      $0.001 par value per share, the Series B-1 Preferred Stock of the Company,
      $.001 par value per share, the Series C Preferred Stock of the Company,
      $0.001 par value per share, and the Series D Preferred Stock of the
      Company, $0.001 par value per share."

      (c)   The fourth sentence of Section 2(b) of the Agreement is hereby
amended by deleting the phrase "Registrable Securities" contained therein and
replacing it with the phrase "Registrable Shares".

      (d)   A new Schedule 5 is hereby added to the Agreement in the form
attached as EXHIBIT A hereto.

2.    JOINDER. Each undersigned holder of shares of the Company's Series D
Preferred Stock hereby agrees that upon execution of this Amendment by such
person or

<PAGE>

entity, such person or entity shall become a party to the Agreement, as amended
by this Amendment, and shall be fully bound by, and subject to, all of the
covenants, terms and conditions of the Agreement, as amended by this Amendment,
as though such person or entity were an original party thereto and shall be
deemed a Holder for all purposes thereof.

3.    GENERAL PROVISIONS.

      (a)   NO OTHER AMENDMENTS. Except for the amendments contained in SECTION
1 of this Amendment, the Agreement shall remain in full force and effect.

      (b)   AUTHORIZATION. Each of Holder (which term shall include the
undersigned holders of shares of the Company's Series D Preferred Stock) hereby
represents and warrants to the Company and to each other that (i) such Holder
has full power and authority to execute, to deliver and to perform such Holder's
obligations under this Amendment; and (ii) the execution and delivery of this
Amendment has been duly and validly authorized, and all necessary action has
been taken to make this Amendment a valid and binding obligation of such Holder,
enforceable in accordance with its terms, except that the enforcement thereof
may be subject to bankruptcy, insolvency, reorganization, moratorium or other
similar laws now or hereafter in effect relating to creditors' rights generally
and to general principles of equity (regardless of whether such enforcement is
considered a proceeding in equity or at law).

      (c)   GOVERNING LAW. This Amendment shall be governed by and construed
under the laws of the State of Delaware, as applied to agreements among Delaware
residents made and to be performed entirely within the State of Delaware, and
without regard to the conflicts of law principles as may otherwise be
applicable.

      (d)   BINDING ON SUCCESSORS. This Amendment shall bind and inure to the
benefit of the parties hereto, their respective heirs, executors,
administrators, successors and permitted assigns.

      (e)   COUNTERPARTS AND SIGNATURE BY FACSIMILE. This Amendment may be
executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. The
facsimile signature of any party to this Amendment for purposes of execution or
otherwise is to be considered as an original signature, and the document
transmitted is to be considered to have the same binding effect as an original
signature on an original document. At the request of any party, any facsimile or
telecopy document is to be re-executed in original form by the parties who
executed the facsimile or telecopy document. No party may raise the use of a
facsimile machine or telecopier or the fact that any signature was transmitted
through the use of a facsimile or telecopier machine as a defense to the
enforcement of this Amendment or any notice required thereof.

                   [THE FOLLOWING PAGE IS THE SIGNATURE PAGE]

<PAGE>

                                    EXHIBIT A

                                   SCHEDULE 5

                                SERIES D HOLDERS

Mark Gehring
John W. Thompson
Roger Chylla
Praveen Sinha
Raymond Kubly
Jeff Rusinow
Tom Plumb
John J. Burke
Marianna Thompson Trust
Herman & Gwen Shapiro Foundation
David G. Walsh
Robert J. Kriz
Thomas Terry
Gary Wendt
GEFUltravisual
James Delaney III Declaration of Trust
J. Maurits Hudig IRA
David and Kim Bethea
MBF Investments (2000) LLC
Philip R. Blake
M&I Trust Co., (FBO Tod B. Linstroth)
Thor Lundgren
Peter Skanavis
Charles F. Stierman
James Riederer
John J. Ouellette
John R. Teitgen
William J. Kalmer CLU, Ltd. Pension Plan
Dennis D. Skogen
John A. Turcott
Michael G. Laskis
Richard T. Daly
Terence F. Kelly
D. King Aymond, M.D.
John and Sally Oulette
Ryan Kubly
Gregory J. Lynch & Eileen K. Schnabel
Cathrine M. Hudig 1972 Trust
Carolyn Bassham 1972 Trust
Barb Rowbotham 1972 Trust

<PAGE>

Schuetz Revocable Trust Alvin & Janice Schuetz
Pat Walsh
Dave Reneicke
Richard Jansen
Henry and Diane Ipsen
Susan P. Daugherty
Greg Larson
Mehta Revocable Trust
Harry Roth
Eric J. Rosenstock
Timothy Reiland
David Wood
Marcus Cohen
Francis M. Corby, Jr.
Gary R. Kuphall
Dennis J. Powers
Whitt C. Case
Jaime Schulz
Richard W. Schulze or Charlene E. Schulze
Norman M. Merz
Philip F. Powondra
Jeffrey O. Jorgenson
James and Joanne Silbernagel Family Trust
Terry Sivesand
Tim O'Brien
Jim Burgess
David Duchow
Dennis Hoffman
Anthony Jasen
Linda A Grey
The Mendota Group
Gregory J. Lynch
Richard A. Latta
John C. Thompson
Ron Reinholtz
Richard Burgess
Parimal

<PAGE>

                                  EMAGEON, INC.

                     =====================================

                              AMENDED AND RESTATED
                          REGISTRATION RIGHTS AGREEMENT

                     =====================================

                                 OCTOBER 2, 2001

<PAGE>

                              AMENDED AND RESTATED

                          REGISTRATION RIGHTS AGREEMENT

      This Amended and Restated Registration Rights Agreement (the "AGREEMENT")
is made and entered into as of October 2, 2001, by and among Emageon, Inc., a
Delaware corporation (the "COMPANY"), those holders of the Series A Preferred
Stock of the Company listed on Schedule 1 attached hereto and made a part hereof
(each, a "SERIES A HOLDER" and collectively, the "SERIES A HOLDERS"), those
holders of the Series B Preferred Stock of the Company listed on Schedule 2
attached hereto and made a part hereof (each, a "SERIES B HOLDER" and
collectively the "SERIES B HOLDERS"), those holders of the Series B-1 Preferred
Stock of the Company listed on Schedule 3 attached hereto and made a part hereof
(each, a "SERIES B-1 HOLDER" and collectively, the "SERIES B-1 HOLDERS"), those
holders of the Series C Preferred Stock of the Company listed on Schedule 4
attached hereto and made a part hereof (each a "SERIES C HOLDER" and
collectively the "SERIES C HOLDERS"), Charles A. Jett, Jr. ("JETT"), and Gary A.
York ("YORK") (each of Jett and York, a "FOUNDER," and collectively, the
"FOUNDERS").

                              W I T N E S S E T H:

      WHEREAS, the Company, the Series A Holders, the Series B Holders and the
Founders have entered into a Registration Rights Agreement, dated June 26, 2000
(the "SERIES B AGREEMENT");

      WHEREAS, the Company has entered into a Series C Preferred Stock Purchase
Agreement of even date herewith (the "PURCHASE AGREEMENT") pursuant to which
certain the Series C Holders are purchasing Series C Preferred Stock of the
Company (the "SERIES C SHARES");

      WHEREAS, the obligation of the Series C Holders to purchase the Series C
Shares under the Purchase Agreement is conditioned upon, among other things, the
amendment and restatement of the Series B Agreement;

      NOW, THEREFORE, in consideration of the mutual covenants and agreements
set forth herein, and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties, intending to be
legally bound, hereby amend and restate the Series B Agreement, and hereby
agree, as follows:

      1.    Certain Definitions. As used in this Agreement, the following terms
shall mean:

      "Commission" means the Securities and Exchange Commission, or any other
federal agency at the time administering the Securities Act.

      "Common Stock" means the Common Stock, $0.001 par value per share, of the
Company.

      "Company" means Emageon, Inc., a Delaware corporation.

                                       13
<PAGE>

      "Exchange Act" means the Securities Exchange Act of 1934, as amended, or
any successor federal statute, and the rules and regulations of the Commission
issued thereunder, as they each may, from time to time, be in effect.

      "Holders" means each of the holders of the Preferred Stock or the
Registrable Shares listed on the Schedules hereto, each transferee of the rights
of any Holder hereunder pursuant to Section 11 hereof, and any other person or
entity who shall become a Holder pursuant to Section 22 hereof.

      "Investor Holders" shall mean each of the Holders who shall hold shares of
Preferred Stock or shares issued upon conversion or exercise of any of the
shares of Preferred Stock.

      "Management Holders" shall mean those Holders who are officers of the
Company and are not Investor Holders.

      "Non-Recoverable Expenses" means salaries and expenses of the Company's
officers and employees performing legal and accounting duties in connection with
the Company's obligations under this Agreement.

      "Preferred Stock" means the Series A Preferred Stock of the Company,
$0.001 par value per share, the Series B Preferred Stock of the Company, $0.001
par value per share, the Series B-1 Preferred Stock of the Company, $.001 par
value per share and the Series C Preferred Stock of the Company, $0.001 par
value per share.

      "Public Offering" means a bona fide offering of Common Stock pursuant to a
Registration Statement.

      "Registrable Shares" means (i) the shares of Common Stock issued or
issuable upon conversion of shares of Preferred Stock, and any other shares of
Common Stock held by a Holder hereunder, and (ii) any other shares of Common
Stock of the Company issued in respect of such shares (because of stock splits,
stock dividends, reclassifications, recapitalizations or similar events).

      "Registration Expenses" means all expenses incurred by the Company in
complying with this Agreement, including, without limitation, (i) all Commission
and any National Association of Securities Dealers, Inc. registration and filing
fees and expenses, fees and expenses of compliance with securities and blue sky
laws (including reasonable fees and disbursements of counsel for the
underwriters in connection with blue sky qualifications of the Registrable
Shares), expenses relating to the preparation and printing of documents and of
certificates representing the Registrable Shares, fees and expenses of any
escrow agent, trustee or custodian acting for the Company, fees and
disbursements of counsel and independent certified public accountants of the
Company (including the expenses of any special audit or "cold comfort" letters
required by or incident to such compliance), reasonable fees and disbursements
of one counsel retained

                                       14
<PAGE>

in connection with each registration under Section 2 or 3 hereunder by the
holders of at least a majority of the Registrable Shares being registered (which
counsel shall be reasonably satisfactory to the Company), and fees and expenses
of any special experts retained by the Company, but excluding the fees and
disbursements of any counsel or other advisors or experts retained by holders of
Registrable Shares (severally or jointly), other than the counsel and experts
specifically referred to above, and excluding any underwriter discounts, fees or
commissions attributable to the sale of the Registrable Shares; and (ii)
Non-Recoverable Expenses.

      "Registration Statement" means a registration statement filed by the
Company with the Commission for a Public Offering and sale of Common Stock of
the Company (other than (i) a registration statement on Form S-4 or Form S-8, or
their successors, or any other form for a limited purpose, (ii) any registration
statement covering only securities proposed to be issued in exchange for
securities or assets of another corporation, (iii) a registration statement
filed in connection with an interest or dividend reinvestment plan, (iv) a
registration relating solely to employee benefit plans or to a transaction
subject to Rule 145 of the Securities Act, or (v) a registration relating to the
sale of indebtedness of the Company).

      "Securities Act" means the Securities Act of 1933, as amended, or any
successor federal statute, and the rules and regulations of the Commission
issued thereunder, as they each may, from time to time, be in effect.

      2.    Demand Registrations.

      (a)   At any time after the expiration of 180 days after the closing of
the Company's initial Public Offering, one or more Investor Holders representing
in the aggregate in excess of 30% of the Registrable Shares then held by all
Investor Holders, may request, in writing, that the Company file a Registration
Statement under the Securities Act. Upon receipt of any such request, the
Company shall promptly give written notice of such proposed registration to all
Holders. Each Investor Holder shall have the right, by giving written notice to
the Company within 15 days after the Company provides its notice, to elect to
have included in such registration such of its Registrable Shares as such
Investor Holder may request in such notice of election. Thereupon, the Company
shall, as expeditiously as possible, use its best efforts to effect the
registration under the Securities Act of all Registrable Shares which the
Company has been requested so to register.

      (b)   If the Investor Holders initiating the registration request
hereunder (the "INITIATING HOLDERS") intend to distribute the Registrable Shares
covered by their request by means of an underwriting, they shall so advise the
Company as part of their request made pursuant to this Section 2 and the Company
shall include such information in the written notice referred to in Section 2(a)
hereof in such event, the right of any Investor Holder to include his or its
Registrable Shares in such registration shall be conditioned upon the inclusion
of such Investor Holder's Registrable Shares in the underwriting. All Investor
Holders proposing to distribute their securities through such underwriting shall

                                       15
<PAGE>

enter into an underwriting agreement in customary form with the underwriter or
underwriters selected for such underwriting. Notwithstanding any other provision
of this Section 2(b), if the managing underwriter with respect to the proposed
offering advises the Investor Holders proposing to sell Registrable Shares that
would otherwise be included in the underwriting that marketing factors require a
limitation on the number of shares to be underwritten, the number of Registrable
Shares that may be included in the underwriting shall be allocated among all
such Investor Holders, including the Initiating Holders, in proportion (as
nearly as practicable) to the amount of Registrable Shares proposed to be
included in the Registration Statement by each such Investor Holder. The Company
may include shares for sale for its own account in any registration pursuant to
this Section 2 only with the consent of the holders of two-thirds of the
Registrable Securities included in such registration; provided, however, that if
the managing underwriter with respect to the proposed offering advises the
Investor Holders proposing to sell Registrable Shares that would otherwise be
included in the underwriting that marketing factors require a limitation on the
number of shares to be underwritten and the Company has included shares for sale
for its own account, then the number of shares that may be included by the
Company in the underwriting shall be reduced prior to the reduction of any
Registrable Shares of Investor Holders.

      (c)   The Company shall not be obligated to effect, or take any action to
effect, any registration pursuant to this Section 2:

            (i)   After the Company has effected three registrations pursuant to
this Section 2 and such registrations have been declared or ordered effective;

            (ii)  If within 12 months prior to such registration request, a
registration of securities of the Company has been effected in which Investor
Holders of Registrable Shares had the right to participate on at least a pro
rata basis relative to all stockholders of the Company entitled to participate
in such earlier registration;

            (iii) If the Company receives such request for registration within
180 days preceding the anticipated effective date of a proposed underwritten
public offering of securities of the Company approved by the Board of Directors
prior to the Company's receipt of such request;

            (iv)  If the Board of Directors reasonably determines in good faith
that effecting such a demand registration at such time would have a material
adverse effect upon a proposed sale of all or substantially all of the assets of
the Company, or a merger, reorganization, recapitalization, or similar
transaction materially affecting the capital structure or equity ownership of
the Company which is actively being negotiated with another party; provided,
however, that the Company may only delay a demand registration for this reason
for a period not exceeding six months (or until such earlier time as such
transaction is consummated or no longer proposed); or

                                       16
<PAGE>

            (v)   If such request for registration includes only Registrable
Shares which may be sold by Holder(s) thereof who may sell all of such Holder's
Registrable Shares in the public market under Rule 144 in a three month period.

      (d)   At the time of any request to register Registrable Shares pursuant
to this Section 2, the Company may at its option direct that such request be
delayed for a period not in excess of three months if, in the opinion of the
Company's Board of Directors, the filing of such Registration Statement would
have a material adverse effect on the Company's ability to complete any pending
or proposed material transaction, provided that such right to delay a request
may be exercised by the Company not more than once in any twelve-month period.

      (e)   The Initiating Holders of any Registration Statement filed pursuant
to this Section shall designate the method of distribution of the Registrable
Shares. The Initiating Holders may designate the managing underwriter (who shall
be the lead underwriter) for any Registration Statement filed pursuant to this
Section, provided such designee is reasonably satisfactory to the Company, and
the Company may designate a co-managing underwriter in such offering, provided
such designee is reasonably satisfactory to Holders representing a majority of
the Registrable Shares to be included in the Registration. The Company shall
afford the underwriters, their accountants and attorneys full access to its
personnel and offices for the purpose of confirming the accuracy and
completeness of the Registration Statement.

      (f)   If in the opinion of the underwriters selected to manage the
underwriting, more Common Stock could be sold than is represented by the
Registrable Shares included in the registration without adversely affecting the
price per share, or with the consent of Holders representing two-thirds of the
Registrable Shares to be included, the Company shall be entitled to expand the
offering to include newly issued Common Stock or Common Stock held by third
parties. If the Common Stock so included represents more than half of all Common
Stock to be offered in the Registration Statement, the registration may, at the
option of the Initiating Holders, be deemed to be an incidental registration
under Section 3, rather than a required registration under this Section 2, and
the registration rights of the Holders provided in Section 2(a) shall remain
fully available as if the registration had originated under Section 3 rather
than under Section 2.

      (g)   Notwithstanding anything set forth elsewhere in this Section 2, the
Company shall have no responsibility to cause a Registration Statement to become
effective (i) at a time when it would be required under the rules and
regulations of the Securities and Exchange Commission to prepare and file
audited financial statements for a period other than a completed fiscal year, or
(ii) when the Company would be required to prepare and file audited financial
statements for a completed fiscal year prior to 90 days following the end of
such year.

      (h)   If any Registration Statement prepared pursuant to this Section 2 is
not filed or does not become effective as a result of the decision of the
Initiating Holders or any underwriter designated by them, the obligation of the
Company to prepare and file a

                                       17
<PAGE>

Registration Statement at the request of such Initiating Holders shall
nevertheless have been satisfied; provided that if the decision not to file the
Registration Statement or to withdraw the Registration Statement prior to it
becoming effective is the result of a material adverse change in the business of
the Company, the registration rights of the Holders provided in Section 2(a)
shall remain fully available as if the registration had not been requested by
the Initiating Holders. If the Registration Statement otherwise fails to become
effective, the registration rights of the Holders provided in Section 2(a)
remain fully available as if the registration had not been requested by the
Initiating Holders.

      3.    Incidental Registration.

      (a)   Whenever the Company proposes to file a Registration Statement in
connection with an offering of its securities solely for cash (other than the
Company's initial public offering, and other than a registration in connection
with a Company stock plan or a registration pursuant to Rule 145 under the
Securities Act) it shall, at such time, promptly give written notice to all
Holders of such registration and, upon the written request of a Holder or
Holders given within 10 days after the Company provides such notice (which
request shall state the intended method of disposition of such Registrable
Shares), the Company shall use its best efforts to cause all Registrable Shares
that the Company has been requested by such Holder or Holders to register to be
registered under the Securities Act to the extent necessary to permit their sale
or other disposition in accordance with the intended methods of distribution
specified in the request of such Holder or Holders; provided, that the Company
shall have the right to postpone or withdraw any registration effected pursuant
to this Section 3 without obligation to any Holder.

      (b)   In connection with any offering under this Section 3 involving an
underwriting, the Company shall not be required to include any Registrable
Shares in such underwriting unless the Holders holding such Registrable Shares
thereof accept the terms of the underwriting as agreed upon between the Company
and the underwriters selected by it and enter into a customary underwriting
agreement, and then only in such quantity as will not, in the opinion of the
managing underwriter, jeopardize the success of the offering by the Company. If
in the opinion of the managing underwriter the registration of all, or any part
of, the Registrable Shares which Holders have requested to be included would
adversely affect such Public Offering, then the Company shall be required to
include in the underwriting only that number of Registrable Shares, if any, that
the managing underwriter believes may be sold without causing such adverse
effect, and the amount of securities to be offered for the accounts of all
persons seeking to include securities of the Company in the Registration
Statement shall be reduced in the following order of priority to the extent
necessary to cause the amount to be included in the Registration Statement not
to exceed the amount recommended by such managing underwriter:

            (i)   first, the amount of securities to be offered for the accounts
of Company stockholders other than Holders ("OTHER STOCKHOLDERS") that do not
have a contractual right to require the Company to include the securities held
by them in a

                                       18
<PAGE>

registration shall be reduced pro rata (based upon the amount of securities each
such person sought to include in the offering) to zero, if necessary,

            (ii)  next, the amount of securities to be offered for the account
of Other Stockholders that have a contractual right (subordinate to the Holders'
rights hereunder) to require the Company to include the securities held by them
in a registration shall be reduced pro rata (based upon the amount of securities
each such person sought to include in the offering) to zero, if necessary,

            (iii) next, the amount of securities to be offered for the account
of Management Holders of Registrable Shares and all Other Stockholders that have
a contractual right (subordinate to the Investor Holders' rights hereunder) to
require the Company to include the securities held by them in a registration
shall be reduced pro rata (based on the amount of securities each such person
sought to include in the offering) to zero, if necessary, and

            (iv)  finally, the amount of securities to be offered for the
account of the Investor Holders of Registrable Shares and all Other Stockholders
that have a contractual right (on parity with the Investor Holders' rights
hereunder) to require the Company to include the securities held by them in a
registration shall be reduced pro rata (based upon the amount of securities each
such stockholder sought to include in the offering) to zero, if necessary.

      4.    Registrations on Form S-3.

      (a)   Notwithstanding any other term or provision of this Agreement, at
such time as the Company shall have qualified for the use of Form S-3
promulgated under the Securities Act, the Investor Holders representing in the
aggregate in excess of five percent (5%) of the Registrable Shares then held by
all Investor Holders shall have the right to request in writing registrations on
Form S-3 (or such successor form) of Registrable Shares, which request or
requests shall (i) specify the number of Registrable Shares intended to be sold
or disposed of, (ii) state the intended method of disposition of such
Registrable Shares, and (iii) relate to Registrable Shares having an anticipated
aggregate offering price of not less than $1,000,000, provided, however, the
Investor Holders may only make one such request in any 12-month period. A
requested registration on Form S-3 pursuant to this Section 4 shall not count as
a registration demanded pursuant to Section 2 hereof. During the pendency of any
offering under this Section 4 if the Company shall inform the Holders that there
is material non-public information regarding the Company, the Holders shall
cease selling activities in such offering and the Company shall promptly advise
the members of its Board of Directors of the material non-public information (to
the extent not previously disclosed to them) and a decision shall be made
whether or when such information should be publicly disclosed. The Holders shall
not recommence selling activities until the Company shall inform the Holders
that there is no material non-public information regarding the Company;
provided, however, the Company shall use its best efforts to insure that the
delay arising out of the failure to disclose such information does not persist
for more than 30 days.

                                       19
<PAGE>

      (b)   The Company shall not be obligated to effect, or take any action to
effect, any registration pursuant to this Section 4:

            (i)   If within 12 months prior to such registration request, a
registration of securities of the Company has been effected in which Investor
Holders of Registrable Shares had the right to participate on at least a pro
rata basis relative to all stockholders of the Company entitled to participate
in such earlier registration;

            (ii)  If the Company receives such request for registration within
90 days preceding the anticipated effective date of a proposed underwritten
public offering of securities of the Company approved by the Board of Directors
prior to the Company's receipt of such request;

            (iii) If the Board of Directors reasonably determines in good faith
that effecting such a demand registration at such time would have a material
adverse effect upon a proposed sale of all or substantially all of the assets of
the Company, or a merger, reorganization, recapitalization, or similar
transaction materially affecting the capital structure or equity ownership of
the Company which is actively being negotiated with another party; provided,
however, that the Company may only delay a demand registration for this reason
for a period not exceeding six months (or until such earlier time as such
transaction is consummated or no longer proposed) and may not utilize this right
more than once in any 12 month period; or

            (iv)  If such request for registration includes only Registrable
Shares which may be sold by Holder(s) thereof who may sell all of such Holder's
Registrable Shares in the public market under Rule 144 in a three month period.

      (c)   At the time of any request to register Registrable Shares pursuant
to this Section 4, the Company may at its option direct that such request be
delayed for a period not in excess of three months if, in the reasonable opinion
of the Company's Board of Directors, the filing of such Registration Statement
would have a material adverse effect on the Company's ability to complete any
pending or proposed material transaction, provided that such right to delay a
request may be exercised by the Company not more than once in any twelve-month
period.

      5.    Registration Procedures. If and whenever the Company is required by
Sections 2, 3, or 4 of this Agreement to use its best efforts to effect the
registration of any of the Registrable Shares under the Securities Act, the
Company shall:

      (a)   file with the Commission a Registration Statement with respect to
such Registrable Shares and use its best efforts to cause that Registration
Statement to become and remain effective for such reasonable period of time as
required to complete the Public Offering;

                                       20
<PAGE>

      (b)   as expeditiously as possible prepare and file with the Commission
any amendments and supplements to the Registration Statement and the prospectus
included in the Registration Statement as may be necessary to keep the
Registration Statement effective for such reasonable period of time as required
to complete the Public Offering, but in no event greater than 180 days and
comply with the provisions of the Securities Act with respect to the disposition
of all shares covered by such Registration Statement.

      (c)   provide the selling stockholders and the underwriters (which terms,
for purposes of this Agreement shall include a person deemed to be an
underwriter within the meaning of Section 2(11) of the Securities Act), if any,
of the shares being sold and counsel for such underwriters and counsel for such
selling stockholders (which counsel shall be subject to approval by the Company,
such approval not to be unreasonably withheld) the opportunity to participate in
the preparation of the Registration Statement, each prospectus included therein
or filed with the Commission, and each amendment or supplement thereto; and make
available for inspection by such selling stockholders or other persons such
financial and other information, books and records of the Company and cause the
officers, directors and employees of the Company and counsel and independent
certified public accountants of the Company to respond to such inquiries as
shall be reasonably necessary, in the opinion of respective counsel to such
selling stockholders and such underwriters, to conduct a reasonable
investigation within the meaning of the Securities Act;

      (d)   promptly notify (in writing, if so requested) the selling
stockholders and the underwriters, if any, (i) when the Registration Statement,
the prospectus or any prospectus supplement or post-effective amendment has been
filed, and with respect to the Registration Statement or any post-effective
amendment, when the same has become effective, (ii) of any material comments by
the Commission with respect thereto or any request by the Commission for
amendments or supplements to the Registration Statement or the prospectus or for
additional information, (iii) of the issuance by the Commission of any stop
order suspending the effectiveness of the Registration Statement or the
initiation of any proceedings for that purpose, (iv) of the occurrence of any
event, at any time during which the Registration Statement remains effective,
that causes the representations and warranties of the Company contemplated by
Section 8 hereof to cease to be true and correct in all material respects, (v)
of the receipt by the Company of any notification with respect to the suspension
of the qualification of the Registrable Shares for sale in any jurisdiction or
the initiation or threatening of any proceeding for such purpose, or (vi) of the
occurrence or failure to occur of any event, or change in circumstance, at any
time when a prospectus is required to be delivered under the Securities Act, as
a result of which the Registration Statement, prospectus, any prospectus
supplement, or any document incorporated by reference in any of the foregoing
contains an untrue statement of a material fact or omits to state any material
fact required to be stated therein or necessary to make the statements therein
not misleading in light of the circumstances then existing;

                                       21
<PAGE>

      (e)   make reasonable efforts to obtain the withdrawal of any order
suspending the effectiveness of a Registration Statement hereunder or any
post-effective amendment thereto at the earliest practicable date;

      (f)   if requested by the managing underwriter or underwriters or by
selling stockholders representing at least a majority of the Registrable Shares
being included in the Registration Statement, promptly incorporate in a
prospectus supplement or post-effective amendment such information as such
managing underwriter or underwriters or such selling stockholders reasonably
specify should be included therein relating to the sale of the Registrable
Shares, including, without limitation, information with respect to the number or
amount of Registrable Shares being sold to such underwriters, the purchase price
being paid therefor by such underwriters and with respect to any other terms of
the underwritten (or best efforts underwritten) offering of the Registrable
Shares to be sold in such offering; and make all required filings of such
prospectus supplement or post-effective amendment promptly after notification of
the matters to be incorporated in such prospectus supplement or post-effective
amendment; provided that the Company and its counsel are reasonably satisfied
that such additional information does not constitute an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the
circumstances then existing;

      (g)   as expeditiously as possible furnish to each selling stockholder
such reasonable numbers of copies of the prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and such
other documents as the selling stockholder may reasonably request in order to
facilitate the Public Offering; and furnish to each selling stockholder and each
underwriter, if any, such number of copies of the Registration Statement, each
amendment and supplement thereto (in each case including all exhibits thereto),
the prospectus included in the Registration Statement (including each
preliminary prospectus and any summary prospectus), in conformity with the
requirements of the Securities Act, and such other documents as such selling
stockholder and underwriter, if any, may reasonably request in order to
facilitate the Public Offering; the Company consents to the use of the
prospectus or any amendment or supplement thereto by each of the selling
stockholders and the underwriters in connection with the offering and sale of
the Registrable Shares covered by the prospectus or any supplement or amendment
thereto;

      (h)   as expeditiously as possible use its best efforts to register or
qualify the Registrable Shares covered by the Registration Statement under the
securities or blue sky laws of such states as the underwriters shall reasonably
request, and do any and all other acts and things that may be reasonably
necessary or desirable to enable the Public Offering to be consummated;
provided, however, that the Company shall not be required in connection with
this Section 5(h) to qualify as a foreign corporation or execute a general
consent to service of process in any jurisdiction;

      (i)   use its best efforts to cause all of the Registrable Shares to be
included in a Registration Statement hereunder to be registered with or approved
by such other

                                       22
<PAGE>

governmental agencies or authorities as may be necessary by virtue of the
business and operations of the Company to enable the Public Offering to be
consummated;

      (j)   facilitate the timely preparation and delivery of certificates
representing Registrable Shares to be sold; and

      (k)   provide a CUSIP number for all Registrable Shares, not later than
the effective date of the Registration Statement.

      If the Company has delivered preliminary or final prospectuses to the
selling stockholders and after having done so the prospectus is amended to
comply with the requirements of the Securities Act, the Company shall promptly
notify the selling stockholders and, if requested, the selling stockholders
shall immediately cease making offers of Registrable Shares and return all
prospectuses to the Company. The Company shall promptly provide the selling
stockholders with revised prospectuses and, following receipt of the revised
prospectuses, the selling stockholders shall be free to resume making offers of
the Registrable Shares.

      6.    Allocation of Expenses. The Company shall pay all Registration
Expenses of all registrations under this Agreement including, without
limitation, Registration Statements that are not declared effective as
contemplated in Section 2(h) hereof, except that after the second registration
under Section 4 hereof, the Registration Expenses for a registration under
Section 4 shall be paid by the participating sellers in proportion to the number
of shares sold by each or as shall otherwise be agreed by such participating
sellers other than the Company (except to the extent the Company shall be a
seller). All underwriting discounts and selling commissions applicable to the
sale of the Registrable Shares shall be borne by the participating sellers in
proportion to the number of shares sold by each or as shall otherwise be agreed
to by such participating sellers other than the Company (except to the extent
the Company shall be a seller).

      7.    Indemnification.

      (a)   In the event of any registration of any of the Registrable Shares
under the Securities Act pursuant to this Agreement, the Company shall indemnify
and hold harmless the seller of such Registrable Shares, each director, officer,
partner, or member of such seller, each underwriter of such Registrable Shares,
and each other person, if any, who controls such seller or underwriter within
the meaning of the Securities Act or the Exchange Act, against any losses,
claims, damages or liabilities, joint or several, including, without limitation,
subject to Section 7(c) hereof, any amounts paid in settlement, to which such
seller, underwriter or controlling person may become subject under the
Securities Act, the Exchange Act, state securities laws or otherwise, insofar as
such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon any untrue statement or alleged untrue statement
of any material fact contained in any Registration Statement under which such
Registrable Shares were registered under the Securities Act, any preliminary
prospectus or final prospectus contained in the Registration Statement, or any
amendment or supplement to such

                                       23
<PAGE>

Registration Statement, or arise out of or are based upon the omission or
alleged omission to state a material fact required to be stated therein or
necessary to make the statements therein not misleading; and the Company shall
reimburse such seller, underwriter and each such controlling person for any
legal or any other expenses reasonably incurred by such seller, underwriter or
controlling person in connection with investigating or defending any such loss,
claim, damage, liability or action; provided, however, (i) that the Company
shall not be liable to any such seller, underwriter or controlling person in any
such case to the extent that any such loss, claim, damage or liability arises
out of or is based upon any untrue statement or omission made in such
Registration Statement, preliminary prospectus or prospectus, or any such
amendment or supplement, in reliance upon and in conformity with information
furnished to the Company, in writing, by or on behalf of such seller or
underwriter or controlling person specifically for use in the preparation
thereof and (ii) provided, however, that the indemnity agreement contained in
this Section 7(a) shall not apply to amounts paid in settlement of any such
loss, claim, damage, liability or action if such settlement is effected without
the consent of the Company, which consent shall not be unreasonably withheld.
Such indemnification and reimbursement of expenses shall remain in full force
and effect regardless of any investigation made by or on behalf of such seller,
its directors, officers, partners, or members such underwriter, its directors or
officers or such controlling person, and shall survive the transfer of any or
all Registrable Shares by such seller.

      (b)   In the event of any registration of any of the Registrable Shares
under the Securities Act pursuant to this Agreement, each seller of Registrable
Shares, severally and not jointly, shall indemnify and hold harmless the
Company, each of its directors and officers, each other seller and each
underwriter, if any, and each person, if any, who controls the Company or any
such underwriter within the meaning of the Securities Act or the Exchange Act,
against any losses, claims, damages or liabilities, joint or several, to which
the Company, such directors and officers, underwriter or controlling person may
become subject under the Securities Act, Exchange Act, state securities laws or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon any untrue statement or alleged
untrue statement of a material fact contained in any Registration Statement
under which such Registrable Shares were registered under the Securities Act,
any preliminary prospectus or final .prospectus contained in the Registration
Statement, or any amendment or supplement to the Registration Statement, or
arise out of or are based upon any omission or alleged omission to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading, if the statement or omission was made in reliance upon
and in conformity with information furnished in writing to the Company by or on
behalf of such seller specifically for use in connection with the preparation of
such Registration Statement, prospectus, amendment or supplement; and each such
seller shall reimburse the Company, each of its directors and officers, each
underwriter and each controlling person for any legal or any other expenses
reasonably incurred by the Company, such directors and officers, underwriters
and controlling persons in connection with investigating or defending any such
loss, claim, damage, liability or action; provided, however, that the indemnity
agreement contained in this Section 7(b) shall not apply to amounts paid in
settlement of any such loss, claim, damage, liability or action if such

                                       24
<PAGE>

settlement is effected without the consent of such seller, provided, further,
however, that, to the extent permitted by law, the indemnification obligation of
each seller of Registrable Shares shall be limited to the net proceeds received
by such selling stockholder in the Public Offering in dispute. Such
indemnification and reimbursement of expenses shall remain in full force and
effect regardless of any investigation made by or on behalf of the Company, its
officers or directors, any such other seller, its officers or directors, or any
such controlling person, and shall survive the transfer of any or all
Registrable Shares by any such other seller.

      (c)   Each party entitled to indemnification under this Section 7 (the
"INDEMNIFIED PARTY") shall give notice to the party required to provide
indemnification (the "INDEMNIFYING PARTY") promptly after such Indemnified Party
has actual knowledge of any claim as to which indemnity may be sought, and shall
permit the Indemnifying party to assume the defense of any such claim or any
litigation resulting therefrom; provided, however, that counsel for the
Indemnifying Party, who shall conduct the defense of such claim or litigation,
shall be approved by the Indemnified Party (whose approval shall not be
unreasonably withheld); provided, however, that an Indemnified party shall have
the right to retain its own counsel (limited to one counsel for all Indemnified
Parties), with the fees and expenses of such counsel to be paid by the
Indemnifying Party, if representation of such Indemnified Party by the counsel
retained by the Indemnifying Party would be inappropriate due to actual or
potential differing interests between such Indemnified Party and any other party
represented by such counsel in such proceeding. The failure by an Indemnified
Party to deliver written notice to the Indemnifying Party within a reasonable
time of the Indemnified Party's discovery of such claim, if materially
prejudicial to its ability to defend such claim, shall relieve the Indemnifying
Party of its obligations under this Section 7 but only to the extent of such
material prejudice. The Indemnified Party may participate in such defense at
such party's expense. No Indemnifying Party, in the defense of any such claim or
litigation shall, except with the consent of each Indemnified Party, consent to
entry of any judgment or enter into any settlement which does not include as an
unconditional term thereof the giving by the claimant or plaintiff to such
Indemnified Party of a release from all liability in respect of such claim or
litigation.

      (d)   (i) If for any reason the indemnification provided for in this
Section 7 is unavailable to or insufficient to hold harmless an indemnified
party under this Section 7 in respect of any losses, claims, damages or
liabilities (or actions in respect thereof) referred to herein, then each
Indemnifying Party shall contribute to the amount paid or payable by such
Indemnified Party as a result of such losses, claims damages or liabilities (or
actions in respect thereof), in such proportion as is appropriate to reflect the
relative fault of each Indemnifying Party and the Indemnified Party as well as
any other relevant equitable considerations; provided, however, that to the
extent permitted by law, the indemnification obligation of each seller of
Registrable Shares shall be limited to the net proceeds received by such Selling
Stockholders in the Public Offering in dispute. The relative fault of each
Indemnifying Party and Indemnified Party shall be determined by reference to,
among other things, whether any action in question, including any untrue or
alleged untrue statement of a material fact or omission or alleged omission to
state a

                                       25
<PAGE>

material fact, has been made by, or relates to information supplied by, such
Indemnifying Party or Indemnified Party, and the parties' relative intent,
knowledge. access to information and opportunity to correct or prevent such
action. The amount paid or payable by a party as a result of the losses, claims,
damages or liabilities referred to above shall be deemed to include, subject to
the limitations set forth in Section 7(c), any legal or other fees or expenses
reasonably incurred by such party.

            (ii)  The parties hereto agree that it would not be just and
equitable if contribution pursuant to this Section 7(d) were determined by pro
rata allocation (even if the sellers or any underwriters or all of them were
treated as one entity for such purpose) or by any other method of allocation
which does not take account of the equitable considerations referred to in the
immediately preceding paragraph. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation.

            (iii) The contribution provided for in this Section 7(d) shall
survive, with respect to a Holder, the transfer of Registrable Shares by such
Holder and with respect to a Holder or the Company shall remain in full force
and effect regardless of any investigation made by or on behalf of any
Indemnified Party.

      8.    Agreements with Respect to Underwritten Offering. In the event that
Registrable Shares are sold pursuant to a Registration Statement in an
underwritten offering pursuant to Section 2 hereof, the Company agrees to enter
into such customary agreements (including an underwriting agreement) and take
such other actions in connection therewith as the Holders representing at least
a majority of Registrable Shares to be included in a Registration Statement
hereunder shall reasonably request in order to expedite or facilitate the Public
Offering and in such connection, whether or not an underwriting agreement is
entered into and whether or not the registration is an underwritten registration
(a) make such representations and warranties to the selling stockholders and the
underwriters, if any, in form, substance and scope as are customarily made in
such a registration; (b) obtain an opinion of counsel to the Company in
customary form and covering such matters of the type customarily covered by such
opinion as the Holders representing at least a majority of Registrable Shares to
be included in such registration and the underwriters, if any, may reasonably
request, addressed to each selling stockholder and the underwriters, if any, and
dated the effective date of such Registration Statement (or, if such
registration includes an underwritten Offering, dated the date of the closing
under the underwriting agreement); (c) obtain a "cold comfort" letter from the
independent certified public accountants of the Company addressed to the selling
stockholders and the underwriters, if any, (and which may also be addressed to
the Board of Directors of the Company) dated the effective date of such
Registration Statement (and, if such registration includes an underwritten
offering, dated the date of the closing under the underwriting agreement), such
letter to be in customary form and covering such matters of the type customarily
covered by such letter; and (d) deliver such documents and certificates as may
be reasonably requested by the Holders representing at least a majority of
Registrable Shares being sold and the managing

                                       26
<PAGE>

underwriters, if any, to evidence compliance with clause (a) above and with any
customary conditions contained in the underwriting agreement or other agreement
entered into by the Company.

      9.    Information by Holder. It shall be a condition precedent to the
obligations of the Company under this Agreement that each Holder of Registrable
Shares to be included in any registration shall furnish to the Company such
information regarding such Holder and the distribution proposed by such Holder
as the Company may request in writing and as shall be required in connection
with any registration, qualification or compliance referred to in this
Agreement.

      10.   Rule 144 Requirements. After the registration by the Company of a
class of securities under Section 12 of the Exchange Act, the Company agrees to:

      (a)   make and keep public information available, as those terms are
understood and defined in Rule 144 (or any successor rule) under the Securities
Act;

      (b)   use its best efforts to file with the Commission in a timely manner
all reports and other documents required of the Company under the Securities Act
and the Exchange Act (at any time after it has become subject to such reporting
requirements); and

      (c)   furnish to any Holder upon request a written statement by the
Company as to its compliance with the reporting requirements of said Rule 144
(at any time after 90 days after the closing of the first sale of securities by
the Company pursuant to a Registration Statement), and of the Securities Act and
the Exchange Act (at any time after it has become subject to such reporting
requirements), a copy of the most recent annual or quarterly report of the
Company, and such other reports and documents of the Company as such Holder may
reasonably request to avail itself of any similar rule or regulation of the
Commission allowing it to sell any such securities without registration.

      11.   Transfer of Rights.

      (a)   The rights granted to a Holder under this Agreement may be
transferred by such Holder to another Holder or to any transferee if (i) there
is transferred to such transferee at least 10% of the Registrable Shares
originally issued by the Company to such transferring Holder and (ii) the
Company is given written notice by the transferee at the time of such transfer
stating the name and address of the transferee and identifying the securities
with respect to which such rights are being assigned; provided that the failure
to provide such notice shall not restrict the transfer and use of the rights
hereunder except to the extent that the Company is materially prejudiced
thereby. Any transferee to whom rights under this Agreement are transferred
shall, as a condition to such transfer, deliver to the Company a written
instrument by which such transferee agrees to be bound by. the obligations
imposed upon Holders under this Agreement to the same extent as if such
transferee were a Holder hereunder.

                                       27
<PAGE>

      (b)   Notwithstanding anything to the contrary herein, any Holder may
transfer rights granted to such Holder under this Agreement to any affiliate of
such Holder, any liquidating trust established with respect to such Holder or
any limited partner stockholder or member of such Holder in connection with a
distribution of assets to such Holder's partners, stockholders or members if
such transferee is a transferee of shares of Preferred Stock or Registrable
Shares and such transferee delivers to the Company a written instrument by which
such transferee agrees to be bound by the obligations imposed upon Holders under
this Agreement to the same extent as if such transferee were a Holder hereunder.
In the event of such transfer, such transferee shall be deemed a Holder for
purposes of this Section 11 and may again transfer such rights to any other
person or entity which acquires shares of Preferred or Registrable Shares from
such transferee, subject to and in accordance with Section 11(a) hereof.

      12.   Other Registration Rights. The Company shall not grant demand
registration rights to any party or any incidental registration rights that are
superior to or pari passu with the incidental registration rights of the
Investor Holders without the written consent of Investor Holders representing in
the aggregate more than 50% of the Registrable Shares then held by such Investor
Holders.

      13.   Amendments and Waivers. Any term of this Agreement may be amended
and the observance of any term of this Agreement may be waived, either generally
or in a particular instance and either retroactively or prospectively, with the
written consent of the Company and Holders representing in the aggregate more
than 50% of the Registrable Shares, provided that no such amendment or waiver of
any term of this Agreement shall affect any outstanding Registrable Shares on a
disproportionate basis without the specific consent of each Holder affected
thereby. Any amendment or waiver effected in accordance with this Section 13
shall be binding upon each Holder, each future Holder and the Company. No
waivers of or exceptions to any term, condition or provision of this Agreement,
in any one or more instance, shall be deemed to be, or construed as, a further
or continuing waiver of any such term, condition or provision. Notwithstanding
anything to the contrary in this Section 13, the Company shall be entitled to
add additional purchasers of Series C Shares pursuant to Section 2.1 of the
Purchase Agreement as parties to this Agreement as and in the manner set forth
in such Section 2.1, and each such additional purchaser shall thereafter be
deemed to be an Investor Holder for all purposes hereunder.

      14.   "Market Stand-Off" Agreement. Each Holder hereby agrees that, during
the period of duration specified by the Company and an underwriter of Common
Stock or other securities of the Company, following the effective date of a
registration statement of the Company filed under the Securities Act, it shall
not, to the extent requested by the Company and such underwriter, directly or
indirectly sell, offer to sell, contract to sell (including, without limitation,
any short sale), grant any option to purchase or otherwise transfer or dispose
of (other than to donees who agree to be similarly bound) any securities of the
Company held by it at any time during such period except Common Stock included
in such registration; provided, however, that such market stand-off time period
shall not exceed 180 days.

                                       28
<PAGE>

      In order to enforce the foregoing covenant, the Company may impose
stop-transfer instructions with respect to the Registrable Shares of each
Investor (and the shares or securities of every other person subject to the
foregoing restriction) until the end of such period.

      Notwithstanding the foregoing, the obligations described in this Section
14 shall not apply to a registration relating solely to employee benefit plans
on Form S-1 or Form S-8 or similar forms. which may be promulgated in the
future, or a registration relating solely to a Commission Rule 145 transaction
on Form S-14 or similar forms which may be promulgated in the future.

      15.   Entire Agreement: Successors and Assigns of the Company.

      (a)   This Agreement embodies the entire agreement and understanding
between the parties hereto with respect to the subject matter hereof and
supersedes all prior agreements and understandings relating to such subject
matter.

      (b)   This Agreement shall be binding, in accordance with its terms, upon
any successor, by way of merger, consolidation, sale of assets or otherwise, of
the Company.

      16.   Counterparts and Signature by Facsimile. This Agreement may be
executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. The
facsimile signature of any party to this Agreement for purposes of execution or
otherwise, is to be considered as an original signature, and the document
transmitted is to be considered to have the same binding effect as an original
signature on an original document. At the request of any party, any facsimile or
telecopy document is to be re-executed in original form by the parties who
executed the facsimile or telecopy document. No party may raise the use of a
facsimile machine or telecopier or the fact that any signature was transmitted
through the use of a facsimile or telecopier machine as a defense to the
enforcement of this Agreement or any notice required thereof.

      17.   Headings. The headings of the sections of this Agreement have been
added for convenience only and shall not be deemed to be a part of this
Agreement.

      18.   Severability. The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
severable provision.

      19.   Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware, without regard for the
conflict of laws rules thereof.

      20.   Notices. All notices and other communications under this Agreement
shall be in writing and shall be (a) sent by facsimile transmission and by
certified or registered mail, return receipt requested, courier or overnight
mail, or (b) sent by certified

                                       29
<PAGE>

or registered mail, return receipt requested, courier or overnight mail (i) if
to any Holder, at the registered facsimile number and address of such Holder as
set forth in the register kept at the principal office of the Company, or (ii)
if to the Company, to 1200 Corporate Drive, Suite 400, Birmingham, Alabama
35242, Attention: Charles A. Jett, Jr., or at such other address or facsimile
number as it shall have furnished in writing to all holders of Registrable
Shares at the time outstanding. Any written communication so addressed, sent by
facsimile transmission or certified or registered mail, return receipt
requested, courier or overnight mail, shall be deemed to have been given when
sent via facsimile or mailed. All other written communications shall be deemed
to have been given upon receipt thereof.

      21.   Termination. All registration rights granted hereunder shall
terminate five (5) years after the date of the Company's initial Public
Offering. Notwithstanding the foregoing, the Company shall in no event be
required to register shares of Common Stock for sale hereunder by any Holder
who, at the time of such registration, would be permitted to sell all such
shares in the public market immediately under Rule 144 as then in effect.

      22.   Subsequent Holders. Subject to Section 12 hereof, the Company shall
be entitled to include additional holders of its capital stock pursuant to any
additional issuance of the Company's capital stock as parties to this Agreement,
and to treat such purchasers as "Holders" hereunder, by executing a counterpart
signature page to this Agreement with such additional holder and amending the
Schedules attached hereto, and upon the execution of such additional signature
page such person shall become a party hereto and such additional signature pages
shall be an original part of this Agreement.

      23.   Mutual Waiver of Jury Trial. THE PARTIES HERETO WAIVE ALL RIGHT TO
TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING BROUGHT TO ENFORCE OR DEFEND ANY
RIGHTS OR REMEDIES UNDER THIS AGREEMENT OR ANY DOCUMENTS RELATED THERETO.

                   [THE FOLLOWING PAGE IS THE SIGNATURE PAGE]

                                       30
<PAGE>

                                   Schedule 1

                                SERIES A HOLDERS

FINN PARTNERS, LLC
THE HUGH H. WILLIAMSON III REVOCABLE TRUST
PARADIGM VENTURE PARTNERS, L.P.
RUSSELL H. MADDOX
CHARLES A. JETT, JR.
STEPHEN L. BARNETT
FRIST FAMILY INTERNET PARTNERS
JOHN P. HAMILTON
BENSON R. MCLENDON AND JOAN G. MCLENDON TENANTS IN COMMON
JOAN G. MCLENDON TTEE BENSON R. MCLENDON, JR. CHILDREN'S TRUST
      U/A DTD. 12/20/95 FBO AMY ELIZABETH MCLENDON

<PAGE>

                                   Schedule 2

                                SERIES B HOLDERS

STF INSTITUTIONAL PARTNERS II, L.P.
STF PARTNERS QP II, L.P.
STF PARTNERS II, L.P.
HARBINGER/AURORA QP VENTURE FUND, L.L.C.
HARBINGER/AURORA VENTURE FUND, L.L.C.
JEMISON INVESTMENT CO., INC.
JAMES D. DAVIS
RICHGOOD CORPORATION
HORGEN ONE INVESTMENT, L.L.C.
SOUTHEASTERN TECHNOLOGY FUND, L.P.
PARADIGM VENTURE PARTNERS, L.P.
GREYSTONE CAPITAL PARTNERS I, L.L.C.
PAUL REAVES

                                       2
<PAGE>

                                   Schedule 3

                               SERIES B-1 HOLDERS

ROPAR, LTD.
ROBTEL, INC.
MMM EMAGEON, L.L.C.
BENSON R. MCLENDON
THE PERMANENTE FEDERATION LLC
KAISER FOUNDATION HOSPITALS
T.I. EMA, INC.

                                       3
<PAGE>

                                   Schedule 4

                                SERIES C HOLDERS

STF INSTITUTIONAL PARTNERS II, L.P.
STF PARTNERS QP II, L.P.
STF PARTNERS II, L.P.
HARBINGER/AURORA QP VENTURE FUND, L.L.C.
HARBINGER/AURORA VENTURE FUND, L.L.C.
JEMISON INVESTMENT CO., INC.
JAMES B. DAVIS
RICHGOOD CORPORATION
PARADIGM VENTURE PARTNERS, L.P.
GREYSTONE CAPITAL PARTNERS I, L.L.C.
MILLER INVESTMENT LLC
WILLIAM D. MELTON
MEI HOLDINGS, LLC
DELTA VENTURE PARTNERS I, L.P.

                                       4<PAGE>

                                                                   EXHIBIT 10.12

  CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE
                   BEEN SEPARATELY FILED WITH THE COMMISSION.

                  EMAGEON UV, INC. MASTER TERMS AND CONDITIONS
                              ENTERPRISE AGREEMENT

THIS EMAGEON ENTERPRISE AGREEMENT (the "Agreement") is made this 5th day of May,
2004 (the "Effective Date"), by and between EMAGEON UV, INC. ("Emageon"), whose
principal place of business is at 1200 Corporate Drive, Suite 400, Birmingham,
Alabama 35242, and ASCENSION HEALTH, ("Ascension Health") whose principal place
of business is at 4600 Edmundson Road, St. Louis MO. 63134. The parties have
structured this Agreement to permit Ascension Health and the Ascension
Affiliates, as defined in Section 1.1, to purchase Emageon's products and
services upon the terms and conditions contained herein. An Order Addendum will
be executed between Emageon and either Ascension Health or an Ascension
Affiliate to detail specifics regarding the products and services purchased.
Throughout this Agreement, the term "Customer" shall refer to any Ascension
Affiliate that is bound by the terms and conditions of this Agreement. Ascension
Health shall have no liability or obligations (financial or otherwise) under
this Agreement or on behalf of an Ascension Affiliate, unless otherwise
specifically set forth in this Agreement or if the Order Addendum is in the name
of Ascension Health.

1.       DEFINITIONS. As used in this Agreement and in addition to any other
         terms defined herein, the following defined terms will have the
         following meanings:

         1.1.     "Ascension Affiliate" means any entity in or with which
                  Ascension Health: (i) is its sole corporate member; (ii) owns
                  more than a 20% ownership interest; (iii) has voting control
                  of the membership interests or managing board; (iv) has an
                  agreement to manage the entity's operations; (v) has
                  officially deemed the entity to be an affiliate via
                  contractual arrangement or memorandum of understanding which
                  agreement or memorandum is not solely for the purpose of
                  providing access to the special corporate discounts; or (vi)
                  has a contract to provide data processing services which are
                  not solely for the purpose of providing access to the special
                  corporate discounts. In addition, Ascension Affiliate shall
                  include any entity which is part of a chain of entities all
                  related in a manner described in items (i) through (vi) above.

         1.2.     "Ascension Ministry" means a group of Ascension Affiliates
                  that have been designated by Customer as an Ascension
                  Ministry.

         1.3.     "Clinical Information System" means an enterprise or
                  departmental electronic health record or departmental
                  information system (e.g. Radiology Information System) which
                  would require the presentation of medical images.

         1.4.     "CPI" means annual percentage increase set forth in the United
                  States Department of Labor Consumer Price Index, all Urban
                  Consumers, U.S. city average, all items with an index base
                  period of (1982-1984= 100).

         1.5.     "DICOM" means Digital Imaging and Communications in Medicine
                  and is the industry standard for transferring radiological
                  images and other medical information between computers.
                  Patterned after the Open System Interconnection of the
                  International Standards Organization, DICOM enables digital
                  communication between diagnostic and therapeutic equipment and
                  systems from various manufacturers.

         1.6.     "Eligible User Population" means all Customer employees,
                  agents, independent contractors, and customers who Customer
                  authorizes to access the SYSTEM.

         1.7.     "Emageon Software" means all computer programming/formatting
                  code or operating instructions created and/or designed by
                  Emageon. Emageon Software includes, but is not limited to, any
                  files necessary to organize, manage, store, transfer,
                  visualize, and retrieve DICOM images or HL7 messages, and
                  similar functions and underlying technology or components,
                  such as image processors, image compression, interface
                  programs that link other programs, customized graphics
                  manipulation

<PAGE>

                  engines, and menu utilities, whether in database form or
                  dynamically driven, all as created and/or designed by Emageon
                  and as set forth in Attachment B of each Order Addendum.

         1.8.     "Facility" means a location utilizing the SYSTEM that is an
                  Ascension Affiliate and part of an Ascension Ministry.
                  Facilities shall be designated in each Order Addendum.

         1.9.     "First Productive Use" means the date when Emageon certifies
                  to Customer that the SYSTEM is fully capable of performing its
                  functions pursuant to its specifications.

         1.10.    "Hardware" means the hardware components necessary for the
                  operation of the SYSTEM as set forth in Attachment B of each
                  Order Addendum.

         1.11.    "Hardware Installation Acceptance" means, unless otherwise
                  provided herein or in the respective Order Addendum, the date
                  Emageon certifies completion of installation of the Hardware
                  in accordance with the mutually agreed upon written
                  installation schedule and plan. If Emageon is prevented from
                  installing the Hardware in accordance with the mutually agreed
                  upon written installation schedule due to Customer's inability
                  to take delivery, or begin installation of the Hardware, the
                  Hardware Installation Acceptance shall be fifteen (15) days
                  after the agreed upon written installation schedule.

         1.12.    "Implementation Services" means those activities associated
                  with the installation and integration of the SYSTEM and
                  described in the respective Installation Plan and as outlined
                  in Exhibit A hereto.

         1.13.    "Installation Acceptance" means the SYSTEM has been installed
                  and tested for a period of thirty (30) days from First
                  Productive Use and has been found to be functional and capable
                  of performing the functions that it is intended to perform
                  when operated by a knowledgeable operator under specified
                  operating conditions. Upon completion of the thirty (30) day
                  testing period, Installation Acceptance shall be effective. If
                  any nonconformity of the SYSTEM is discovered by the Customer
                  during the thirty (30) day test period, Customer shall notify
                  Emageon in writing immediately upon the discovery of such
                  nonconformity and Emageon shall make every effort to correct
                  such nonconformity within ten (10) days unless another period
                  of time is mutually agreed upon by both parties and evidenced
                  in writing signed by both parties. Should Emageon be prevented
                  from installing the SYSTEM in accordance with the mutually
                  agreed upon written Installation Plan due to delays caused
                  solely by the Customer then the SYSTEM shall be deemed
                  installed and accepted forty-five (45) days after the agreed
                  upon Installation Acceptance date as set forth in the
                  Installation Plan. Upon Installation Acceptance, Emageon shall
                  invoice the respective Customer for all fees associated with
                  the Installation Acceptance. Should Installation of the SYSTEM
                  be delayed solely due to the fault of the other party, the
                  delayed party may recover from the delaying party actual
                  expenses incurred as a direct result of such delay.

         1.14.    "Installation Plan" means the mutually agreed upon series of
                  milestones that must be accomplished and the target dates for
                  such milestones. A sample installation plan is set forth in
                  Exhibit F. A custom installation plan shall be developed for
                  each Customer Facility within two weeks, or as mutually agreed
                  upon, of the execution of an appropriate Order Addendum and
                  each such custom installation plan shall be incorporated into
                  the appropriate Order Addendum.

         1.15.    "Integrating the Healthcare Enterprise" (IHE) is a joint
                  initiative by the Radiological Society of North America (RSNA)
                  and the Healthcare Information and Management Systems Society
                  (HIMSS), focused on improving the way computer systems in
                  healthcare share information. IHE promotes coordinated use of
                  established communications standards such as DICOM and HL7 to
                  address specific clinical needs in support of efficient
                  patient care. A dynamic and evolving standard, IHE members
                  submit, negotiate and agree upon implementation profiles to be
                  used for transactions allowing medical images and patient data
                  to be shared across an enterprise.

         1.16.    "Intellectual Property Rights" means any and all rights
                  existing from time to time in any jurisdiction under patent
                  law, copyright law, moral rights law, trade-secret law,
                  semiconductor chip protection law, trademark law, unfair
                  competition law, or other similar rights.

         1.17.    "Material Breach" means that either party fails to carry out
                  its obligations as set forth in this Agreement. Examples of
                  Material Breach include, but are not limited to, the failure
                  of the SYSTEM to perform

<PAGE>

                  substantially in accordance with the documentation such that
                  the operations of the Customer are impacted OR the failure of
                  the Customer to make undisputed payments.

         1.18.    "Modality" means a medical acquisition device such as Magnetic
                  Resonance, Computed Tomography, Nuclear Medicine, Ultrasound
                  and the like used in clinical departments such as Radiology
                  and Cardiology.

         1.19.    "Order Addendum" means the document in substantially the form
                  of Exhibit I attached hereto that will be executed by Emageon
                  and a Customer for each order of Hardware, Software,
                  Implementation Services, and Professional Services.

         1.20.    "Professional Services" means those activities requested by
                  Customer that are beyond the scope of the Implementation
                  Services and Support Services as set forth in Exhibit B of
                  each Order Addendum. An example of Professional Services would
                  be migration of legacy data. Professional Services fees are
                  billed separately from the SYSTEM fees and shall be set forth
                  in a separate Statement of Work. Professional Services will be
                  provided to Customer at the Professional Services Rates.

         1.21.    "Professional Services Rates" means those rates for
                  professional services as set forth in Exhibit J hereto.

         1.22.    "Services" means use of and access to the SYSTEM.

         1.23.    "Software" means the combined Emageon Software and Third Party
                  Software.

         1.24.    "Study" means an imaging service or procedure request with a
                  DICOM Study Instance Unique Identifier, which may consist of
                  multiple series from multiple modalities.

         1.25.    "SYSTEM" means the Emageon Software, Third Party Software and
                  Hardware as generally set forth in Attachment B of each Order
                  Addendum.

         1.26.    "System Upgrades" means any improvement in the Software that
                  enhances or modifies the basic function of the Software or any
                  new software that Emageon markets as a replacement of or
                  upgrade to the Software.

         1.27.    "System Updates" means any improvement in the Software that
                  relates to operating performance but does not alter the basic
                  function of the Software.

         1.28.    "Third Party Software" means all computer software created by
                  a third party (whether supplied in this Agreement or licensed
                  during the term hereof) in which the intellectual property
                  rights are not owned by Emageon, including without limitation,
                  any computer software specified as such in Attachment B of
                  each Order Addendum.

         1.29.    "Total Accountability Services" means the highest level of
                  Emageon Service and Support options for software and hardware,
                  including but not limited to; extended service hours,
                  additional consulting and analysis services, system monitoring
                  capabilities, additional training services, integration
                  services, business and financial performance metrics and
                  reporting.

2.       EMAGEON OBLIGATIONS.

         2.1.     Emageon shall provide Customer with use of the SYSTEM, which
                  shall be installed by Emageon in accordance with Exhibit A and
                  Attachment E of each Order Addendum and supported through the
                  term of this Agreement in accordance with Exhibit B.

         2.2.     Emageon agrees to work in good faith with Customer and the
                  Customer's Clinical Information Systems vendors, including but
                  not limited to those Clinical Information System vendors
                  listed on Exhibit K, to interface the SYSTEM with the
                  Customer's Clinical Information Systems. The appropriate fees
                  for such interface shall be agreed upon by both parties and
                  shall be set forth in the respective Order Addendum. In no
                  case shall the fees exceed the Professional Services Rates.

<PAGE>

         2.3.     Within thirty (30) days of the execution of this Agreement,
                  Emageon shall name a relationship manager to be the primary
                  point of contact for all joint activities.

         2.4.     Emageon agrees to provide as part of the SYSTEM, * * *. Also,
                  Emageon agrees to provide as part of the SYSTEM, * * *. Note
                  that there are separate Professional Services fees for * * *.
                  Failure of Emageon to achieve the results in a commercially
                  acceptable fashion within the timeframes set forth above,
                  shall result in Emageon paying Customer liquidated damages
                  equal to * * *.

         2.5.     Emageon intends to provide * * * to be priced at mutually
                  agreed to rates. As of the date of this Agreement, Emageon
                  supports * * * within the Ultrastructure Software. However,
                  should Emageon not provide * * * as intended, there shall be
                  no recourse to Emageon or this Agreement.

         2.6.     Emageon agrees to work with Ascension to develop the proper
                  platform and network configuration to enable an infrastructure
                  that will allow multiple, geographically dispersed Facilities
                  to share efficiently in a single common archive. This solution
                  must allow for proper security and scalability to support a
                  multiple Facility implementation and comply with regulatory
                  constraints and common industry practices on medical record
                  access.

         2.7.     Emageon represents and warrants that it will continuously
                  provide support for and be actively engaged in research and
                  development with respect to the SYSTEM for a period that is
                  the lesser of: (i) * * *; or (ii) * * *. The foregoing support
                  shall be provided to Customer at no additional charges to
                  Customer except for fees set forth herein.

         2.8.     While at the Customer locations, Emageon and Emageon
                  employees, agents and subcontractors ("Emageon Personnel")
                  shall (1) comply with reasonable requests, standard rules and
                  regulations of Customer regarding personal and professional
                  conduct (including the wearing of a particular uniform,
                  identification badge, or personal protective equipment and
                  adhering to health care facility regulations which in some
                  instances may include health screening and testing, and
                  general safety practices or procedures) generally applicable
                  to such locations and (2) otherwise conduct themselves in a
                  businesslike manner. In the event that Customer determines in
                  good faith that the continued assignment to the project of one
                  or more persons is not in the best interests of Customer (and
                  provided the basis for such determination is not prohibited by
                  law), Customer shall consult with Emageon to that effect. Upon
                  such consultation, Emageon shall have a reasonable period of
                  time in which to investigate the matters stated in such
                  notice, discuss its findings with Customer and resolve the
                  problems with such person. If, following such period, Customer
                  requests replacement of such person, Emageon shall replace
                  that person with another person of suitable ability and
                  qualifications. However, where Customer notifies Emageon that
                  Customer has determined that the nature of the concern is such
                  that such person should be removed immediately from Customer's
                  account, Emageon shall immediately remove such individual(s)
                  from Customer's account pending such investigation and
                  discussion. In any event, any request by Customer to remove an
                  individual from Customer's account shall not be deemed to
                  constitute or require a termination of such individual's
                  employment by Emageon and in no event shall Customer be deemed
                  an employer of any such person. Notwithstanding the foregoing,
                  in no event shall Emageon be required to remove a person from
                  the project under this Section if Emageon believes in good
                  faith that doing so might subject Emageon to legal liability
                  for so doing, provided that Emageon provides Customer with the
                  rationale for its belief.

3.       CUSTOMER OBLIGATIONS.

         3.1.     Customer shall have full responsibility for preparing,
                  maintaining and supporting those Modalities not provided by
                  Emageon in Attachment B of each Order Addendum. This includes,
                  but is not limited to, preventative maintenance, quality
                  control, following clearly defined technique and acquisition
                  procedures, and generally maintaining the system such that it
                  operates to its manufacturer's most recent specifications.
                  Further, the Customer is responsible for insuring these
                  Modalities are prepared to begin transmitting, and can
                  appropriately deliver DICOM data to the SYSTEM in the format
                  provided for by Emageon. In the event Emageon needs to provide
                  additional DICOM integration services, for

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

                  non-standard DICOM integrations, additional Professional
                  Service fees will apply. Emageon may, in certain
                  circumstances, provide for, as identified in Attachment B of
                  each Order Addendum, a DICOM interface device to the legacy,
                  non-DICOM Modality. In this event, those DICOM interface
                  devices will be maintained by Emageon in accordance with
                  Emageon's responsibilities identified in Exhibit B.
                  Professional Services charges will apply for standard DICOM
                  modality integrations occurring outside the scope of this
                  Agreement.

         3.2.     Customer shall have full responsibility for preparing,
                  maintaining and supporting its information systems such as its
                  hospital information system, radiology information system and
                  any interface devices used to consolidate the information
                  systems. Typical support costs for these information systems,
                  which are the responsibility of the Customer, include general
                  maintenance, adding extra connectivity points and upgrades and
                  updates to those information systems.

         3.3.     Customer shall have full responsibility for preparing,
                  maintaining and supporting the necessary infrastructure
                  required to operate the SYSTEM. This includes, but is not
                  limited to, facilities, both wide area and local area
                  networks, heating and cooling systems, and electrical and
                  other energy sources, including uninterruptible power systems
                  and electrical back-up devices.

         3.4.     Customer shall be responsible for preventing any virus
                  infections, security breaches, and other disabling events
                  ("Disabling Event") from damaging the SYSTEM. Consequently,
                  Customer shall use a reliable and commercially accepted virus
                  detection system on any software and hardware that interfaces
                  to the SYSTEM. Customer must also have in place antivirus and
                  information systems security policies and procedures. In the
                  event that the SYSTEM is subject to a Disabling Event,
                  Customer shall immediately notify Emageon and Emageon shall
                  work with Customer in order to bring the system back to
                  pre-Disabling Event status. All time, materials and expense
                  involved with Emageon's investigation, planning and execution
                  of a SYSTEM rebuilding plan shall be billed separately to
                  Customer at the Professional Services Rates. Additionally, any
                  SYSTEM down time attributable to a Disabling Event shall not
                  count against non-scheduled down time. Not withstanding the
                  foregoing, however, any Disabling Event resulting from an act
                  or omission committed in breach of Emageon's obligations as
                  set forth in this Agreement shall be remedied by Emageon at no
                  cost to Customer and any SYSTEM downtime attributable to such
                  a Disabling Event shall count against non-scheduled downtime.

         3.5.     Software Upgrades. Customer agrees that they will install all
                  Software Upgrades to the Emageon Software such that they are
                  never behind more than the version that was generally in
                  release * * *.

         3.6.     Within thirty (30) days of the execution of this Agreement,
                  Customer shall name a relationship manager to be the primary
                  point of contact for all joint activities.

4.       USE AND ACCESS TO THE SYSTEM.

         4.1.     Subject to the terms, conditions and limitations set forth in
                  this Agreement, Emageon grants Customer and the Eligible User
                  Population a non-transferable perpetual right to access and
                  use the Software ("Perpetual License"). The rights granted
                  hereunder include without limitation the right to reproduce or
                  copy all or any portion of the Documentation included with the
                  SYSTEM in machine-readable or printed form as determined by
                  Customer to be reasonably required for its own internal data
                  processing needs. Customer may make and use as many copies of
                  the Software as are reasonably appropriate only for archival,
                  backup and recovery purposes. In connection with Emageon
                  performing the Services, Emageon may develop modifications to
                  the Software and/or new software programs (collectively, the
                  "Developed Software"). Emageon reserves all rights to the
                  Developed Software, including, but not limited to, all
                  Intellectual Property Rights therein. Emageon hereby grants to
                  Customer a non-exclusive, non-transferable right to use the
                  Developed Software solely for use with the SYSTEM and subject
                  to the rights set forth in this Section 4.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

         4.2.     The right to use the SYSTEM granted hereunder and the terms
                  and conditions of this Agreement shall cover all custom
                  Software and related Documentation developed on a
                  time-and-materials or flat-fee basis by Emageon at Customer's
                  request.

         4.3.     Customer will not remove any proprietary notices of Emageon or
                  third parties found in or on the Software. The Emageon
                  Software in both object and source code form, and all rights
                  to the Emageon Software, including but not limited to the
                  Intellectual Property Rights therein, are and will remain the
                  exclusive property of Emageon. Customer will have no claim of
                  ownership to the Intellectual Property Rights in the Emageon
                  Software or any Third Party Software. Customer will have no
                  right to sublicense either the Emageon Software or the Third
                  Party Software or allow access to the SYSTEM to unauthorized
                  users. All data-source documents provided by Customer and all
                  output based upon those documents shall remain Customer's
                  property.

         4.4.     Customer and Emageon acknowledge and agree that the provisions
                  of this Agreement do not prohibit Customer from utilizing a
                  third party to manage and operate the SYSTEM on its behalf
                  ("Outsourcer"). Outsourcer shall have all the rights granted
                  to Customer herein solely for the purpose of providing
                  services to and making the SYSTEM available for Customer's
                  use.

5.       PAYMENTS.

         5.1.     Fees. Pricing as set forth in Attachment C of each Order
                  Addendum is calculated based upon information provided and
                  approved by Customer as set forth in the Site Survey attached
                  as Attachment A of each Order Addendum. Should Customer add
                  equipment, Emageon shall work with Customer in good faith to
                  determine whether any additional charges should apply to a
                  change in its equipment configuration from that set forth in
                  Attachments A and B of each Order Addendum.

         5.2.     Overage Fees. Customer agrees that should a Facility * * * ,
                  Emageon may charge an Overage Fee equal to * * * of the
                  Ultrastructure Software and Maintenance fees for that
                  Facility.

                  In the event that the study volumes increase by more than * *
                  * for any reason other than those as set forth above in any
                  year over the projected study volumes for that year as set
                  forth in Attachment C of the respective Order Addendum,
                  Emageon may charge an Overage Fee equal to * * * of the
                  Ultrastructure Software and Maintenance fees for that
                  Facility. Payment for such overages, if any, shall be
                  considered one-time annual fees due to Emageon within thirty
                  (30) days of completion of such usage audit. Overage
                  calculations and related fees for any given year are
                  independent of overage calculations and related fees for any
                  other year. Customer also acknowledges that it may be required
                  to purchase additional hardware in order to support such
                  overage.

         5.3.     Billing. Emageon will bill Customer for all fees and expense
                  reimbursements due under the terms of this Agreement as set
                  forth in Exhibit C and in Attachment C of each Order Addendum.
                  Unless otherwise specified in this Agreement or an Order
                  Addendum, Customer will pay the undisputed amount of such bill
                  within thirty (30) days after the date of such bill. For each
                  year of this Agreement, Emageon will bill Customer the annual
                  fee on a pro rata monthly basis. Within forty-five (45) days
                  of the end of each year of this Agreement, Emageon and
                  Customer will perform an audit of the prior year's actual
                  billable amounts. Subject to Section 5.2 above, any amounts
                  due Emageon after the audit will be due thirty (30) days after
                  the date of the completion of the audit.

         5.4.     Late Fees. Emageon may assess Customer a late fee of 1% per
                  month (not to exceed the maximum allowed under state law) on
                  all undisputed balances not paid when due.

         5.5.     Disputes. Any fees subject to reasonable dispute by Customer,
                  provided that Customer has notified Emageon in writing of the
                  basis for the dispute within 30 days of date of disputed
                  invoice, will not be subject to monthly late fees or be used
                  as a basis for suspending the services. Should dispute not be
                  settled by members of the respective accounting departments
                  within 30 days of Emageon's receipt of notice of disputed
                  invoice, a face to face negotiation shall be conducted by
                  senior executive representatives of Emageon and Customer.
                  Should the executive representatives be unable to resolve

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

                  such dispute within fourteen (14) days, either party may then
                  seek all remedies available at law. Should either party
                  institute an appropriate suit, the non-prevailing party in
                  such suit shall be responsible for any and all associated
                  costs, including reasonable attorney's fees.

         5.6.     Professional Service Fees. The Professional Service Rates
                  shall apply for all services rendered by Emageon which are
                  outside the scope of this Agreement. Reasonable and customary
                  expenses incurred by Emageon while engaged in such work,
                  including without limitation, expenses incurred for travel,
                  including local transportation, lodging and meals in
                  accordance with Exhibit E, will be billed to Customer at
                  Emageon's actual cost. Best efforts will be made by Emageon so
                  that no Fees outside the scope of this Agreement are incurred
                  without the prior written approval of the Customer.

         5.7.     Renewal Term Fees. For each renewal term, the Annual Support
                  and Maintenance fees for the Ultrastructure and/ or DICOM
                  Cache Manager Software License Fees shall be * * *. The fees
                  for the annual Support and Maintenance for both the
                  Ultrastructure and/ or DICOM Cache Manager Software as well as
                  the Ultravisual Software shall continue at the rates set forth
                  in this Exhibit C plus an adjustment to reflect the CPI for
                  the twelve (12) months immediately preceding the effective
                  date of the Renewal Term or * * *, whichever is lesser. All
                  other appropriate service fees as set forth herein shall be
                  billed to Customer at the then-current rates in accordance
                  with the terms of Exhibit C.

         5.8.     Expenses. Customer will pay or reimburse Emageon for any
                  reasonable out-of-pocket expenses, including, without
                  limitation, travel and travel-related expenses, incurred by
                  Emageon in connection with the implementation and support of
                  the SYSTEM pursuant to Emageon's expense and travel policy
                  attached hereto as Exhibit E.

         5.9.     Taxes. Customer will pay all sales, use, transfer, privilege,
                  excise, charges, surcharges or other taxes, and all duties,
                  whether international, national, state or local, however
                  designated, which are levied or imposed by reason of the
                  transactions contemplated hereby (collectively, the "Taxes");
                  excluding, however, income taxes on profits which may be
                  levied against Emageon. Customer will pay the amount of any
                  Taxes applicable to the transactions contemplated hereby, or
                  in lieu thereof, Customer will provide Emageon with a tax
                  exemption certificate acceptable to the applicable taxing
                  authorities. Customer will indemnify and hold Emageon harmless
                  from and against any and all losses, damages, penalties, costs
                  and expenses, including legal and accounting fees, incurred or
                  suffered by Emageon which result from or arise out of any
                  liability or taxes arising from a failure to pay Taxes under
                  this Agreement.

         5.10.    * * *

6.       RECORDS.

         6.1.     Customer shall keep reasonably accurate records for a period
                  of one (1) year after the close of each calendar year during
                  the term of this Agreement sufficient to allow Emageon to
                  determine the amount of fees to be paid by Customer to
                  Emageon. Such records shall be open to inspection, upon five
                  (5) days prior notice to Customer, by Emageon or an
                  independent certified public accountant retained by Emageon at
                  its own expense; provided, however, that if as a result of
                  such audit it is determined that Customer has underpaid fees
                  by an amount greater than * * *, Customer shall reimburse
                  Emageon for the costs of such audit. Emageon reserves the
                  right to access Customer's SYSTEM in order to audit the SYSTEM
                  and verify the number of Studies stored. Emageon will not
                  adversely effect the clinical operations of the SYSTEM
                  whenever it gains access to the SYSTEM. The scheduling of all
                  such access shall be mutually agreed upon.

7.       PROPRIETARY INFORMATION.

         7.1.     Definitions. For purposes of this Agreement, (a) "Confidential
                  Information" means any data or information of a party that is
                  valuable to such party or its owner and is not generally known
                  by the public, other than Trade Secrets; (b) "Trade Secrets"
                  means any information of a party including, but not limited
                  to, technical or non-technical data, a formula, a pattern, a
                  compilation, a program, a device,

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

                  a method, a technique, a drawing, a process, financial data,
                  financial plans, the Software or any Third Party Software,
                  product plans, or a list of actual or potential customers or
                  suppliers which (i) derives economic value, actual or
                  potential, from not being generally known to, and not being
                  readily ascertainable by proper means by, other persons who
                  obtain economic value from its disclosure or use; and (ii) is
                  the subject of efforts that are reasonable under the
                  circumstances to maintain its secrecy; and (c) "Proprietary
                  Information" means Confidential Information and Trade Secrets.

         7.2.     Non-Disclosure. Each party acknowledges that during the term
                  of this Agreement, the other party may be providing certain of
                  its Proprietary Information to such party, including but not
                  limited to the SYSTEM, which will be maintained by Emageon,
                  and the DICOM images provided by Customer to Emageon. Each
                  party will take reasonable precautions necessary to safeguard
                  the confidentiality of the Proprietary Information of the
                  other party, including those taken by such party to protect
                  its own Proprietary Information. Without limiting the
                  foregoing, each party agrees that it shall not, without the
                  prior written consent of the other party, directly or
                  indirectly, copy, disclose, distribute, publish, reproduce,
                  decompile, reverse engineer, transfer or make use of the
                  Proprietary Information of the other party except in
                  connection with the rights granted under this Agreement. Nor
                  shall either party disclose the contents of this Agreement,
                  pricing in connection with this Agreement, or the content of
                  any Emageon proposal materials to any third parties except for
                  outside legal counsel and/or accountants; provided, however,
                  that should it become necessary to disclose said information
                  to a third party, the disclosing party shall notify the
                  non-disclosing party, in writing, in advance and the third
                  party shall execute the non-disclosing party's non-disclosure
                  agreement before the disclosing party discloses said
                  information. Emageon recognizes that relevant Proprietary
                  Information may be shared by and between Ascension Health and
                  Ascension Affiliates provided such individuals agree to be
                  bound by the terms of Non-Disclosure set forth in this Section
                  7.

         7.3.     Unauthorized Disclosure. If an unauthorized use or disclosure
                  occurs, such party will immediately notify the other party and
                  assist the other party in recovering its Proprietary
                  Information and preventing its subsequent unauthorized use or
                  dissemination. However, the restrictions of this Agreement on
                  use and disclosure of Proprietary Information shall not apply
                  to information that:

                  (a)      is in the possession or control of the non-disclosing
                           party at the time of its disclosure hereunder;

                  (b)      is, or becomes, publicly known through no wrongful
                           act of non-disclosing party;

                  (c)      is received by non-disclosing party from a third
                           party free to disclose it without obligation to the
                           disclosing party; or

                  (d)      is independently developed by non-disclosing party
                           without the use of any Proprietary Information.

         7.4.     Term of Non-Disclosure. The restrictions set forth in this
                  Section 7 shall continue (i) with respect to the Trade Secrets
                  for as long as such information continues to be a Trade Secret
                  under applicable law, and (ii) with respect to Confidential
                  Information, during the term of this Agreement and for a
                  period of five (5) years from the date of its expiration or
                  termination.

         7.5.     Use of Customer Proprietary Information. Customer grants to
                  Emageon the non-exclusive right to use Customer's Proprietary
                  Information (including any data) obtained under this Agreement
                  for Emageon's internal purposes in order to perform the
                  Services and as otherwise set forth in this Agreement. Nothing
                  in this paragraph shall limit Emageon's obligations under this
                  Section 7 in any way.

         7.6.     Use of Enhancements, Discoveries, Processes. All customized or
                  custom computer software programs developed by Emageon at
                  Customer's request, and all materials furnished by Emageon in
                  conjunction with such programs, shall be the exclusive
                  property of Emageon, * * *.

         7.7.     Confidential Information shall not include any protected
                  health information. Such information shall only be governed by
                  the terms of Exhibit D, the Business Associate Agreement

8.       CUSTOMER INDEMNIFICATION.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

         8.1.     In addition to the other obligations of indemnification stated
                  herein, Customer will indemnify and hold Emageon and its
                  affiliates, officers, directors, employees, agents and
                  representatives harmless from and against all damages, costs,
                  expenses, and liabilities, including without limitation,
                  reasonable attorneys' fees and expenses, from any third party
                  claim of any kind against Emageon arising, in whole or in
                  part, from (a) Customer's negligence or willful misconduct
                  arising under this Agreement and (b) Customer's use of the
                  data accessed through the SYSTEM.

9.       EMAGEON WARRANTIES AND INDEMNIFICATION.

         9.1.     Emageon grants Customer the limited, nontransferable warranty
                  that the Services will be (i) performed in a workman-like
                  manner in accordance with normally accepted industry
                  standards, and (ii) performed by qualified personnel. If
                  Emageon fails to satisfy the foregoing warranty, then Customer
                  will notify Emageon in writing of such failure as soon as
                  reasonably practicable but in no event later than * * * after
                  completion of the Services.

         9.2.     Emageon represents and warrants that it either owns or has the
                  right to grant the rights set forth herein, and that the
                  Emageon Software does not infringe any third party copyright,
                  patents, trade secrets, or other proprietary rights,
                  enforceable in the United States. Emageon's sole liability for
                  any breach of the foregoing representations will be to
                  indemnify, defend, and hold Customer and its Eligible User
                  Population harmless from and against any and all losses,
                  damages, penalties, costs and expenses, including legal and
                  accounting fees, and to pay any final judgment or settlement
                  of any claim incurred or suffered by Customer which results
                  from or arises out of any claim or liability that the Emageon
                  Software infringes any third party copyright, patent, or other
                  proprietary rights enforceable in the U.S. or misappropriates
                  any third party trade secret enforceable in the U.S.
                  (individually, an "Indemnified Claim" and collectively, the
                  "Indemnified Claims"). The Indemnification set forth in this
                  Section is contingent upon Customer promptly notifying Emageon
                  of an Indemnified Claim, Emageon having the sole authority to
                  defend or settle the Indemnified Claim, and receiving the
                  reasonable assistance of Customer in connection therewith at
                  Emageon's expense. Notwithstanding the foregoing, Emageon will
                  have no indemnification obligation hereunder with respect to
                  any claim based on (i) use of the Emageon Software except in
                  accordance with this Agreement and Emageon's written
                  instructions, (ii) the combination of the Emageon Software
                  with any other software or hardware, unless as directed or
                  approved by Emageon (iii) modifications of the Emageon
                  Software not made by Emageon, or (iv) Customer's failure to
                  implement changes recommended by Emageon, that do not
                  materially alter the functionality or degrade performance of
                  the SYSTEM, if the infringement would have been avoided in the
                  absence of such combination, modifications or failure to
                  implement recommended changes. If the Emageon Software is
                  finally determined by a court of competent jurisdiction to
                  constitute an infringement of any third party patent,
                  copyright or other proprietary right enforceable in the U.S.
                  or a misappropriation of a third party trade secret and
                  Customer's use of the SYSTEM is enjoined, Emageon will either
                  (i) procure the right for Customer to continue to use the
                  SYSTEM as contemplated hereunder, or (ii) replace or modify
                  the SYSTEM with a version thereof that is not infringing and
                  that does not materially alter the functionality or degrade
                  the performance of the System. If a court of competent
                  jurisdiction determines that none of these alternatives is
                  reasonably available, Customer agrees that Emageon may
                  terminate Customer's and its employees' access to the SYSTEM
                  in accordance with the conversion and termination provisions
                  as set forth by such court. In the event of such termination,
                  Emageon agrees to * * *. This Section states the entire
                  liability of Emageon with respect to infringement or
                  misappropriation of any third party Intellectual Property
                  Rights by the Emageon Software and Emageon will have no
                  additional liability with respect to any alleged or proven
                  infringement. Emageon will pass to Customer all appropriate
                  warranties and indemnification provisions from third-party
                  suppliers.

         9.3.     In addition to the other obligations of indemnification stated
                  herein, Emageon will indemnify and hold Customer and its
                  affiliates, officers, directors, employees, agents and
                  representatives harmless from and against all damages, costs,
                  expenses, and liabilities, including without limitation,
                  reasonable attorneys' fees and expenses, from any third party
                  claim of any kind against Customer arising, in whole or in
                  part, from (a) Emageon's negligence or willful misconduct
                  arising under this Agreement and (b) Emageon's use of the data
                  accessed through the SYSTEM.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

         9.4.     Emageon shall provide, at no charge to Customer, * * *.

         9.5.     Emageon represents and warrants that the Software will be the
                  latest available releases, and that future releases and
                  engineering changes to the Software will not degrade
                  performance or remove functionality. Emageon warrants that the
                  SYSTEM will meet or exceed its published specifications.

         9.6.     Emageon represents and warrants that the Software as delivered
                  to Customer neither contains nor shall contain any "Disabling
                  Code" or "Unauthorized Code." As used in this paragraph the
                  term "Disabling Code" means any code, routine, or procedure
                  that has the effect of terminating or disabling execution of
                  the Software. As used in this paragraph, the term
                  "Unauthorized Code" means any virus, Trojan horse, worm, or
                  other code, routine, or procedure that (i) permits
                  unauthorized access to data, software, or systems; or (ii)
                  disables, erases, or otherwise damages software, hardware, or
                  data.

         9.7.     Emageon warrants and represents that the occurrence in or use
                  by the SYSTEM of any dates, including, without limitation, any
                  date with a year specified as "99" or "00," regardless of
                  other meanings attached to these values, and any date before,
                  on, or after January 1, 2000 ("Millenial Dates") will not
                  adversely affect its performance with respect to
                  date-dependent data, computations, output, or other functions
                  (including, without limitation, calculating, comparing, and
                  sequencing) and that the SYSTEM will create, store, process,
                  and output information related to or including Millenial Dates
                  without errors or omissions and at no additional cost to
                  Customer. At Customer's request, Emageon will provide
                  sufficient evidence to demonstrate the adequate testing of the
                  SYSTEM to meet the foregoing requirements.

         9.8.     Emageon agrees to work with each Facility to establish a
                  mutually agreeable performance expectation for the speed of
                  accessing and viewing the first image on the client
                  workstation monitor ("Response Time Service Level"). In each
                  Order Addendum, the Facility and Emageon shall mutually agree
                  to criteria for monitoring and measuring the Response Time
                  Service Level as is appropriate for such Facility's
                  implementation. The variables for this speed shall include but
                  are not limited to workstation capabilities and LAN
                  specifications set forth in the respective Order Addendum. In
                  the event that Customer workstation performance falls below
                  the performance expectation, in accordance with the Order
                  Addendum, Emageon will evaluate the cause of such diminished
                  performance and, at its cost, implement necessary modification
                  to allow Customer to achieve the mutually agreed upon
                  performance level. If Customer wishes to implement changes to
                  the Site Survey Specifications as set forth in the Order
                  Addendum, then Emageon shall provide new workstation and LAN
                  specifications to Customer and continue to honor the Response
                  Time Service Level.

                  9.8.1.   Unless otherwise specified in the Order Addendum, the
                           Diagnostic Viewstation shall display the first image
                           of a fully processed, locally available, unread study
                           request within * * *. Provided, however, the
                           recommended specifications listed in the table below
                           are in place.

<TABLE>
<CAPTION>
       LOCAL AREA NETWORK                             RECOMMENDED
       ------------------                             -----------
<S>                                          <C>
Within PACS Computer Room                    100BaseT Switched
                                             Two 1000BaseT multi-media fiber modules
                                             with SC connection for Archive
Backbone between PACS Computer Room
and Radiology Department                     1000BaseT
Modalities and CR Devices                    10BaseT or 100BaseT Switched
Diagnostic Viewstations                      1000BaseT Switched
Non Diagnostic and Web Viewing               100BaseT Switched
Secure remote LAN access                     VPN for remote diagnostic users
</TABLE>

Note: Diagnostic performance criteria above assumes compliance with the
recommended specifications for Diagnostic Viewstation.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

10.      CUSTOMER WARRANTY. Customer represents and warrants that: (i) Customer
         is the owner, valid licensee, or authorized user of all data provided
         to the SYSTEM and/or Emageon under this Agreement from whatever source;
         and (ii) the use of Customer's data by Emageon as set forth in this
         Agreement will not infringe the Intellectual Property Rights of any
         third party or constitute a misappropriation of any third party trade
         secrets, or constitute a defamation, invasion of privacy, or violation
         of any right of publicity or other third party right. Customer will
         indemnify and hold Emageon harmless from and against any and all
         losses, damages, penalties, costs and expenses, including legal and
         accounting fees, incurred or suffered by Emageon which result from or
         arise out of any claim or liability arising as a result of a breach of
         this Section.

11.      DISCLAIMER OF WARRANTIES. EXCEPT AS EXPRESSLY INDICATED IN THIS
         AGREEMENT, NEITHER PARTY MAKES ANY EXPRESS OR IMPLIED WARRANTIES,
         CONDITIONS OR REPRESENTATIONS TO THE OTHER PARTY WITH RESPECT TO THE
         EMAGEON SOFTWARE, THE THIRD PARTY SOFTWARE, THE SYSTEM, THE SERVICES
         PROVIDED HEREUNDER, THE DATA, OR OTHERWISE, WHETHER ORAL OR WRITTEN,
         EXPRESS, IMPLIED OR STATUTORY. WITHOUT LIMITING THE FOREGOING, ANY
         IMPLIED WARRANTY OR CONDITION OF MERCHANTABILITY, THE IMPLIED WARRANTY
         OR CONDITION OF FITNESS FOR A PARTICULAR PURPOSE, AND THE IMPLIED
         WARRANTY OF NONINFRINGEMENT ARE EXPRESSLY EXCLUDED AND DISCLAIMED.

12.      TERM AND TERMINATION.

         12.1.    The term of this Agreement shall commence on the Effective
                  Date and continue in effect for a period which shall expire
                  with the expiration of the last effective Order Addendum
                  executed hereunder. Each Order Addendum shall have an initial
                  term of sixty (60) months ("Order Addendum Initial Term") and
                  shall automatically renew for additional ninety (90) day
                  successive terms or of a length as agreed upon in writing by
                  both parties (each a "Renewal Term"), unless either party
                  provides written notice to the other party at least ninety
                  (90) days prior to the end of the then-current term of its
                  intent not to renew the term of such Order Addendum.

         12.2.    In the event that either party hereto materially breaches or
                  defaults in the performance of any of its duties or
                  obligations under the Agreement and does not substantially
                  cure such breach or default within thirty (30) days after
                  being given written notice specifying the breach or default,
                  then the non-breaching/defaulting party may, by giving written
                  notice thereof to the breaching/defaulting party, terminate
                  this Agreement as of a date specified in such notice of
                  termination which in no event shall exceed one hundred and
                  eighty (180) days after the notice is given. In the event that
                  Emageon terminates this Agreement or an Order Addendum due to
                  a Customer's material breach or default, or Ascension
                  terminates this Agreement or a Customer terminates its Order
                  Addendum for any reason other than Emageon's material breach
                  or default, all remaining but unpaid fees relating to such
                  terminated Order Addendum shall accelerate and become due and
                  payable within thirty (30) days of termination. If the
                  Agreement is terminated as a result of Emageon's breach, any
                  fees paid by Customer for products and services at the
                  individual Facility impacted by such breach but unearned by
                  Emageon should be refunded retroactively to the date of
                  Emageon's breach. * * *.

         12.3.    Upon expiration of this Agreement or in the event of
                  termination of this Agreement by Customer for cause, Emageon
                  shall provide Customer * * *, or as mutually agreed by both
                  parties (the "Conversion Period"), Software Support and
                  Maintenance and other applicable Total Accountability Services
                  for the purpose of converting to a new system. After such
                  time, Emageon shall no longer have any obligation to provide
                  such support. During the Conversion Period, Emageon's support
                  fees shall be billed at the rate charged during the term
                  immediately prior to the expiration or termination of this
                  Agreement. Should Customer have terminated this Agreement
                  without cause or Emageon terminates the agreement for cause,
                  the aforementioned fees during the conversion period will be
                  increased by * * *.

         12.4.    Upon expiration or termination of this Agreement, Emageon will
                  provide, at no charge to Customer, Customer's data on the
                  media on which the data were stored during the term of this
                  Agreement. If other transfer of image archive data format is
                  desired, Emageon will provide documented software programs
                  that will migrate image files from the SYSTEM to removable
                  media. The data will be stored in DICOM Part 10 files,
                  according to the DICOM 3.0 standard, in uncompressed or
                  compressed format

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

                  or the then current DICOM standard format or replacement
                  thereto. Any other data migration or conversion requested by
                  Customer will be performed under a separate agreement and will
                  involve additional charges. Emageon services, including
                  telephone support, associated with Customer data migration
                  will be charged at the Professional Service Rates.

         12.5.    Termination of this Agreement by either party pursuant to the
                  provisions of this Section 12 shall terminate each party's
                  obligations under this Agreement except for the provisions of
                  Sections 1 and 5-12, all of which shall survive termination of
                  this Agreement.

13.      LIMITED LIABILITY.

         13.1.    BOTH PARTIES AGREE THAT THE OTHER PARTY AND ITS AFFILIATES,
                  OFFICERS, DIRECTORS, EMPLOYEES, SHAREHOLDERS, AGENTS,
                  LICENSORS, OR REPRESENTATIVES WILL NOT BE LIABLE FOR ANY
                  INCIDENTAL, INDIRECT, SPECIAL, EXEMPLARY OR CONSEQUENTIAL
                  DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES OR COSTS
                  INCURRED AS A RESULT OF LOSS OF TIME, LOSS OF SAVINGS, LOSS OF
                  DATA, LOSS OF PROFITS, OR LOSS OF GOODWILL, WHETHER
                  FORESEEABLE OR UNFORESEEABLE, THAT MAY ARISE OUT OF OR IN
                  CONNECTION WITH THIS AGREEMENT, INCLUDING, BUT NOT LIMITED TO,
                  DAMAGES OR COSTS RESULTING FROM THE USE OR INABILITY TO USE
                  THE SYSTEM OR SERVICES, EVEN IF SUCH PARTY HAS BEEN NOTIFIED
                  OF THE POSSIBILITY OR LIKELIHOOD OF SUCH DAMAGES OR COSTS
                  OCCURRING, AND WHETHER SUCH LIABILITY IS BASED ON CONTRACT,
                  TORT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY OR
                  OTHERWISE.

         13.2.    IN NO EVENT WILL THE COLLECTIVE LIABILITY OF EMAGEON AND
                  EMAGEON'S AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES,
                  SHAREHOLDERS, AGENTS, LICENSORS OR REPRESENTATIVES FOR ANY
                  DAMAGES INCURRED BY CUSTOMER EVER EXCEED THE FEES PAID BY
                  CUSTOMER TO EMAGEON UNDER THIS AGREEMENT DURING THE * * *
                  PRIOR TO THE TIME AT WHICH THE DAMAGES AROSE REGARDLESS OF THE
                  FORM OF ACTION, WHETHER BASED ON CONTRACT, TORT, NEGLIGENCE,
                  STRICT LIABILITY, PRODUCTS LIABILITY OR OTHERWISE EXCLUDING
                  SUCH ACTIONS ARISING FROM EMAGEON'S INDEMNIFICATION
                  OBLIGATIONS, GROSS NEGLIGENCE OR THE INTENTIONAL MISCONDUCT OF
                  EMAGEON, ITS EMPLOYEES OR AGENTS.

         13.3.    THE FOREGOING LIMITATION OF LIABILITY AND LIMITATION OF
                  REMEDIES CONTAINED IN SECTIONS 13.1 AND 13.2 SHALL BE
                  INAPPLICABLE TO DAMAGE RESULTING FROM THE NEGLIGENCE OR
                  INTENTIONAL MALFEASANCE OF EMAGEON, ITS DIRECTORS, OFFICERS,
                  EMPLOYEES, AGENTS, AND SUBCONTRACTORS.

14.      NOTICES.

         14.1.    Any notice, approval, request, authorization, direction or
                  other communication under this Agreement shall be given in
                  writing and shall be deemed to have been delivered and given
                  for all purposes (i) on the delivery date if delivered
                  personally to the party to whom the same is directed; (ii) one
                  business day after deposit with a commercial overnight
                  carrier, with written verification of receipt, or (iii) five
                  business days after the mailing date whether or not actually
                  received, if sent by U.S. certified mail, return receipt
                  requested postage and charges pre-paid or any other means of
                  rapid mail delivery for which the receipt is available, to the
                  address of the party set forth below:

<TABLE>
<CAPTION>
CUSTOMER:                                   EMAGEON:
<S>                                         <C>
Ascension Health                            Emageon UV, Inc.
4600 Edmundson Road                         1200 Corporate Drive, Suite 400
St. Louis MO. 63134                         Birmingham, AL 35242
Attn: General Counsel                       Attn: Chief Financial Officer
</TABLE>

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

15.      MISCELLANEOUS.

         15.1.    Force Majeure. In the event that either party's performance
                  (other than the payment of fees) is delayed, prevented,
                  obstructed or inhibited because of any act of nature, fire,
                  casualty, delay or disruption in transportation, flood, war,
                  strike, lockout, epidemic, destruction or shut-down of
                  facilities, shortage or curtailment, riot, insurrection,
                  governmental acts or directives, any full or partial failure
                  of any communications or computer network or any cause beyond
                  such party's reasonable control, the party's performance will
                  be excused and the time for the performance will be extended
                  for the period of delay or inability to perform resulting from
                  such occurrence. The occurrence of such event will not
                  constitute grounds for a declaration of default by either
                  Party.

         15.2.    Publicity. Ascension Health reserves the right to review and
                  approve any press release and/ or marketing materials Emageon
                  plans to issue regarding the execution of this Agreement or
                  written materials identifying Customer as a customer of
                  Emageon unless included in a listing of ten (10) or more
                  customers.

         15.3.    Technical Advisory Councils. * * *.

         15.4.    Assignment. Neither party shall assign or transfer this
                  Agreement or any of its rights or obligations hereunder
                  without the prior written consent of the other, which consent
                  shall not be unreasonably withheld. This Agreement shall inure
                  to the benefit of and bind the parties' successors and
                  permitted assigns.

         15.5.    Waiver. The failure of either party to insist upon the
                  performance of any provision herein or to exercise any right
                  or privilege granted to it hereunder, will not be construed as
                  a waiver of such provision or any provisions herein, and the
                  same will continue in full force. The various rights and
                  remedies given to or reserved by either party herein or
                  allowed by law, are cumulative, and no delay or omission to
                  exercise any of its rights will be construed as a waiver of
                  any default or acquiescence, nor will any waiver of any breach
                  or any provision be considered a condonement of any continuing
                  or subsequent breach of the same provision.

         15.6.    Governing Law. The Agreement and the Services will be governed
                  by and interpreted in accordance with the internal laws of the
                  state of Missouri, excluding its conflict of law rules.

         15.7.    Interpretation. This Agreement sets forth the entire agreement
                  between the parties relating to the subject matter hereof, and
                  supersedes any and all prior agreements of the parties with
                  respect to the subject matter hereof.

         15.8.    Modification and Execution. No change, amendment or
                  modification of any provision of this Agreement shall be valid
                  unless set forth in a written instrument signed by the duly
                  authorized representatives of both parties. This Agreement may
                  be executed in counterparts, each of which shall be deemed an
                  original and all which together shall constitute one and the
                  same document. To the extent there is any conflict between
                  terms contained in the main body of this Agreement and the
                  exhibits to this Agreement, the terms contained in the
                  exhibits to this Agreement shall control. If any provision of
                  this Agreement shall be held to be illegal, invalid or
                  unenforceable, such illegality, invalidity or unenforceability
                  shall apply only to such provision and shall not in any manner
                  affect or render illegal, invalid or unenforceable any other
                  provision of this Agreement, and that provision and this
                  Agreement generally shall be reformed, construed and enforced
                  so as to most nearly give lawful effect to the intent of the
                  parties as expressed in this Agreement.

         15.9.    Regulatory Compliance. Emageon shall comply with the
                  provisions of the Administrative Simplification section of the
                  Health Insurance Portability and Accountability Act of 1996,
                  Public Law 104-91 ("HIPAA"), and the applicable requirements
                  of any regulations promulgated thereunder including without
                  limitation the federal privacy regulations as contained in 45
                  CFR Parts 160 and 164 (the "Federal Privacy Regulations"), as
                  and when such laws and regulations apply to Emageon in the

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

                  capacity of Business Associate of Customer. Such provisions
                  are set forth in the Emageon, Inc. Business Associate
                  Agreement attached hereto as Exhibit D.

         15.10.        Access to Books and Records. To the extent that Section
                  952 of the Omnibus Reconciliation Act of 1980 ("Act") and the
                  regulations promulgated thereunder are applicable to this
                  Agreement, Emageon and the organizations related to it, if
                  any, performing any of the duties pursuant to this Agreement
                  valued at ten thousand dollars ($10,000.00) or more in any
                  twelve (12)-month period shall, until four (4) years after the
                  furnishing of Services pursuant to this Agreement, comply with
                  requests by the Comptroller General, the Secretary of Health
                  and Human Services, and their duly authorized representatives
                  for access (in accordance with Section 952 of the Act) to any
                  contract or agreement between Emageon and Customer for
                  Services and to any contract or agreement between Emageon and
                  such related organizations, as well as the books, documents,
                  and records of Emageon and its related organizations, if any,
                  which are necessary to verify the cost of the Services
                  provided.

         15.11.        Excluded Provider. Emageon hereby represents, and
                  warrants that it is not an excluded provider under the
                  Medicare/Medicaid programs ("Excluded Provider"). Furthermore,
                  in the event that Emageon is ever deemed to be an Excluded
                  Provider, Customer may terminate any and all payment
                  obligations to Emageon without resulting in a breach of the
                  Agreement and may terminate the Agreement without liability or
                  payment to Emageon. Any licenses granted hereunder to the
                  SYSTEM shall automatically convert to perpetual, royalty-free
                  licenses to use, copy, and modify such property for Customer's
                  internal use upon termination of the Agreement pursuant to
                  this Section 15.11. Emageon reserves the right of Assignment
                  as set forth in Section 15.4 so that its products and related
                  services may be transferred to a provider that is not
                  classified as Excluded.

         15.12.        Source Code * * *. Upon occurrence of one or more of the
                  foregoing * * *, Customer shall receive a perpetual, fully
                  paid-up, non-exclusive license to use * * *.

         15.13.        * * *.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by
their duly authorized representatives and made effective as of the Effective
Date.

ACCEPTED AND AGREED TO:                   ACCEPTED AND AGREED TO:

Emageon:                                  Customer:
EMAGEON UV, INC.                          Ascension Health

By: /s/ W. Randall Pittman                By: /s/ Anthony R. Tersigni
    -------------------------                 -------------------------

Name: W. Randall Pittman                  Name: Anthony R. Tersigni

Its:  CFO                                 Its:  Chief Operating Officer
                                                & Interim CEO

<PAGE>

EXHIBITS

A.       Emageon Archive and Distribution System Implementation Services

B.       Emageon Support and Services

C.       Term and Fees

C.1      Terms and Fees - Detail

D.       Business Associate Agreement

E.       Emageon, Inc. Corporate Travel Guidelines

F.       Project Acceptance Process

G.       Adoption Success Management Services

H.       Emageon PACS Administrator Services

I.       Order Addendum

J.       Professional Services Rates

K.       Clinical Information Systems Vendors

<PAGE>

                                    EXHIBIT A

                     EMAGEON ARCHIVE AND DISTRIBUTION SYSTEM
                             IMPLEMENTATION SERVICES

PROJECT MANAGEMENT

Joint Responsibilities

Emageon and Customer are jointly responsible for the management of the project
and for providing the necessary resources to the project. To be effective in
achieving these objectives, the project management team will establish:

-        An agreed-upon baseline for scope, budget and schedule

-        A process for monitoring progress

-        A communication protocol

-        An approach for dealing with issues

-        A change control procedure

-        An approach for formally accepting project deliverables

-        A definition of what constitutes project completion

-        Roles and responsibilities (Customer and Emageon)

-        An approach for tracking and mitigating risk

-        Training tools provided

The following table provides a high level overview of the major and minor
milestones that are typically accomplished during an implementation upon
execution of an Order Addendum.

<TABLE>
<CAPTION>
            PHASE                                                      MILESTONES
            -----                                                      ----------
<S>                                                <C>
* * *                                              * * *
Adoption Communication Planning                    -    Communication and training plan - developed and
                                                        initiated
* * *                                              * * *
* * *                                              * * *
</TABLE>

Emageon Responsibility

Emageon will coordinate and assume lead responsibility for the installation and
integration of the SYSTEM. Emageon will lead and work closely with Customer to
accomplish the listed activities below:

System Design And         Design System Hardware And Software Configuration For
Configuration             Projected Usage Volume And Required Redundancy.

Workflow And Operating    Documentation Of System Configuration.
Procedures

                          Development Of Backup Strategy.

                          Documentation Of Administrator And User Procedures.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

* * *                     * * *

Functional Testing        Functional Testing Of System Components.

Administrator and End     Train Administrator(s) On Routine Operation,
User Training             Maintenance, And Support Of System.

* * *                     * * *

Emageon will be the primary point of contact (POC) for all vendors providing
Emageon-supplied components and services. Customer will be POC for vendors
providing Customer-supplied components and services.

Customer Responsibilities (Details in Table A-4 - Site Readiness Survey)

-        Provide Available Personnel and Facilities According To Mutually Agreed
         Upon Installation And Implementation Schedule

-        Provide Necessary Working / Office Space

-        Provide Access To Facilities

-        Provide Necessary Communications Support - Telephone, Internet Access,
         Etc

-        Insure Customer-Provided Facilities, Information Systems and Modalities
         are prepared, maintained and operational for integration into the
         SYSTEM

-        Review Project Products Within A Given Time Frame

-        Participate In Technical Meetings

-        Deliver Information or Products To The Project

-        Provide a Dedicated System Administrator Relieved of Duties Not Related
         To The Implementation of The Emageon Solution

Customer will make personnel and facilities available according to a mutually
agreed upon schedule. In the event that activities must be rescheduled or
extended due to Customer's non-compliance with the agreed upon schedule,
Customer will bear the cost of rescheduling according to the then-current
professional service rates as specified in Exhibit J.

INSTALLATION ACCEPTANCE

The SYSTEM shall be deemed installed and accepted in accordance with Section
1.13 of this Agreement.

TRAINING

As applicable to the SYSTEM, * * *. As applicable to the SYSTEM, Emageon will
provide training for System Administrators, Diagnosticians, Technologists,
Physicians and applicable clinical staff. Emageon will provide refresher
training, as Customer deems necessary, with major upgrades to the SYSTEM.

* * *

TRANSITION TO SERVICE

Emageon will provide trained personnel to assist with the Transition to Service
of the SYSTEM. The SYSTEM will be deemed to have Transitioned to Service when
the agreed to tasks are complete.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

Customer will make personnel and facilities available according to a mutually
agreed upon schedule. In the event that activities must be rescheduled or
extended due to Customer's non-compliance with the agreed upon schedule,
Customer will bear the cost of rescheduling according to the then-current
professional service rates.

TRAVEL AND LIVING EXPENSES

Customer shall pay or reimburse Emageon for any out-of-pocket expenses,
including, without limitation, travel and travel-related expenses in accordance
with Sections 5.3, 5.4, 5.5 and 5.8 of this Agreement.

CHANGE ORDER PROCESS

In the event there is a need to modify the scope of this Agreement, a change
order process will be utilized. All change orders, which will be detailed in
writing and typically include SYSTEM and Service changes, will define the scope
of such changes which are outside this Agreement. The Emageon POC and Customer
POC will work jointly in creation of the change order. Emageon will not process
nor begin such work until written Customer approval is received. All payment
terms with respect to the change order requests will be defined in the change
order document.

<PAGE>

                                    EXHIBIT B

                           EMAGEON SUPPORT AND SERVICE

Emageon Services and related customer responsibilities are detailed below by
function. Customer shall perform the duties as assigned below.

GENERAL

Customer has full responsibility for hardware, software, and services that are
outside the scope of this Agreement. Customer must operate the equipment on an
ongoing basis, with software that has been approved by Emageon. Customer shall
not install any software or hardware on the SYSTEM without receiving prior
Emageon approval. Customer shall bear all expenses associated with Emageon
service in the event a SYSTEM issue is attributed to Customer installing
non-conforming hardware or software.

Emageon shall not be responsible for support of the SYSTEM if Customer modifies
the SYSTEM without Emageon's authorization.

CUSTOMER RESPONSIBILITIES

Customer shall be responsible for day-to-day operations of the SYSTEM, including
the equipment, preventative maintenance, operating systems and software
applications, and shall continue to provide first line support for the SYSTEM,
as set forth in the Agreement. Customer shall provide the necessary personnel to
meet its obligations under this section, with at a minimum, a dedicated,
full-time SYSTEM Administrator with the skills and experiences necessary to
perform the functions outlined below:

SYSTEM Administration

-        Points of Contact To Emageon On SYSTEM Related Issues

-        Day to Day Operations of SYSTEM

         -        Monitor Image Workflow and Procedures

         -        Archiving / Routing / Pre-Fetching

         -        Correcting Broken Studies

         -        Editing Patient Demographics

         -        Monitoring HIS / RIS Interface

         -        Monitor / Track System Performance

         -        Conduct Component / System Training

-        SYSTEM Troubleshooting / Attempt Repair

-        Assisting With Upgrades and Remote Repairs

-        Document Issues Identified by End Users

Network Administration

-        Perform Daily, Weekly, and Monthly Routine Maintenance Procedures as
         Required

-        Perform Backup / Disaster Recovery Procedures, Including Off-Site
         Storage

-        Perform File System Checks

-        Manage / Size / Tune Storage Parameters

-        Run Performance Tools

-        Manage System Utilities / Generate Reports

-        Monitor and Insure SYSTEM Security Procedures are Being Followed

-        Maintain Site and Environment per Specifications

-        Coordinate New Modality Integration (Post System Acceptance)

<PAGE>

-        Configure and Manage Network Settings

-        Monitor / Analyze / Tune Network Infrastructure

Preventative Maintenance

Customer will perform daily and monthly routine maintenance procedures and
maintain the associated logbook of training provided at the time of
installation. These procedures include verification of automated daily backups
of the database and hierarchical storage management file structure and removal
of backup/disaster recovery copies of tapes to remote sites.

Customer will provide a location for off-site, waterproof, and fireproof storage
of back-ups and disaster recovery copies of data, databases, protocols and user
preferences.

EMAGEON SYSTEM AVAILABILITY

Guaranteed Emageon SYSTEM Availability

1.       Emageon SYSTEM Availability is defined as the ability to archive,
         distribute and view medical image data and interface with other
         information systems. The Guaranteed Emageon System Availability will
         become effective after the Emageon SYSTEM has been accepted at each
         Facility as provided for in the Implementation Plan.

2.       Emageon SYSTEM Availability is measured * * *, commencing with the date
         of SYSTEM Acceptance and ending * * *.

3.       If the Emageon SYSTEM is unavailable for more than * * * then the
         affected Facility shall receive a credit * * *, to be applied to * * *,
         equal to * * *. If the Emageon SYSTEM is unavailable for more than * *
         *, then the affected Facility shall receive a credit * * * to be
         applied to * * *, equal to * * *.

4.       If the Emageon SYSTEM is unavailable for more than * * * during a * *
         *, commencing from the SYSTEM Acceptance and measured thereafter * * *,
         then such Facility may terminate the Agreement as it applies to such
         Facility without penalty or additional charge ("Service Level Failure
         Termination"). Further, if the Emageon SYSTEM is unavailable for more
         than * * * during a * * *, commencing from the SYSTEM Acceptance and
         measured thereafter * * *, then such Facility may terminate the
         Agreement as it applies to such Facility without penalty or additional
         charge ("Service Level Failure Termination").

5.       The measurement for downtime will begin upon Customer providing notice
         to Emageon of the SYSTEM unavailability, as required in this Exhibit B,
         and will end upon the availability of the Emageon SYSTEM.

6.       Scheduled maintenance and upgrades will not count as Emageon Software
         downtime. Scheduled maintenance and upgrades will be scheduled at least
         one week in advance and not exceed * * *. The foregoing limitations and
         restrictions on scheduled maintenance and upgrades may be waived or
         extended by mutual written agreement of Customer and Emageon.

7.       Customer shall have full responsibility for Guaranteed Hardware
         Availability. Hardware downtime will not count against Emageon Software
         downtime unless such downtime was caused by the Emageon Software. Any
         Hardware down time events, which cause the Emageon Software to fail,
         will not count against non-scheduled Emageon Software downtime. In the
         event a Hardware downtime occurs, thereby causing the Emageon Software
         to fail, whether planned or not, all time, materials and expenses
         involved with Emageon's support of such down time event, shall be
         billed separately to Customer at Emageon's then current Professional
         Service fees.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

8.       Remedies provided for in this Exhibit are acknowledged and agreed to
         serve as liquidated damages and not penalties.

Guaranteed Component Availability

         1.       Components are defined as equipment or software within the
                  SYSTEM that acquire, archive, distribute, and allow viewing of
                  medical image data (e.g. a DICOM Interface Box or a DICOM
                  Viewstation) and interface with other information systems. A
                  Component is unavailable if it cannot perform its design
                  function at rated capacity. The Guaranteed Component
                  Availability will become effective after the SYSTEM has been
                  accepted.

         2.       Component Availability is measured * * * assuming 365 days x
                  24 hours per day of operation each year.

         3.       Component downtime resulting in SYSTEM downtime will count
                  only toward the cumulative SYSTEM downtime.

         4.       If an Emageon Component is unavailable for * * *, then the
                  Facility shall receive a credit for such * * *, to be applied
                  to the subsequent * * * billings, equal to * * * of the * * *
                  Software Maintenance and Support Fee, for each unavailable
                  Component.

         5.       The measurement for Component downtime will begin upon
                  Emageon's receipt of notification, as required in this Exhibit
                  B, and will end upon the restoration of Component
                  Availability.

         6.       Scheduled maintenance and upgrades will not count as Component
                  downtime. These functions will be scheduled by mutual
                  agreement.

EMAGEON RESPONSIBILITY

Emageon will provide * * * during the term of this Agreement. These updates will
be scheduled in advance at a time agreed to be mutually acceptable. Emageon will
provide refresher training as Emageon deems necessary for SYSTEM Updates.

Emageon will provide SYSTEM Upgrades. Such upgrades shall be designed and
delivered at Emageon's sole discretion. These upgrades will be scheduled in
advance at a time agreed to be mutually acceptable.

Emageon will act as primary point of contact for all third-party products
comprising the SYSTEM.

Computed Radiography Plates

CR Cassette Plates are consumable products. Emageon warrants that the CR
Cassette plates that are included in the original CR purchase will be free from
defects for a period of ninety days after Installation Acceptance.

EMAGEON SERVICE SUPPORT

The Customer Technical Points of Contact (as designated in the respective Order
Addendum), will be the primary contact for all Customer users to report problems
associated with the equipment. The Customer Technical Points of Contact shall
notify Emageon of the existence of the problem by telephone and the parties
shall mutually classify each problem with a severity level using the criteria
set forth below. All contact to Emageon should be through the Emageon Service
Support line at 1-866-Emageon, option 4. Upon entry of the

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

service ticket and classification of the severity level, Emageon shall
communicate to the Technical Points of Contact the ticket entry and
classification. To the extent the Technical Points of Contact, in their
reasonable opinion, disputes the severity level assigned, such Technical Points
of Contact may contact Emageon to reclassify the incident to a different
severity level. If an incident is reclassified, due to such reasonable dispute,
by the Technical Points of Contact the response time expectation for such
incident shall be the earlier of: (i) the designated response time for the
original severity level classification from the time and date of the original
incident ticket; or (ii) the designated response time for the new severity level
classification from the time and date of notice of reclassification by the
Technical Points of Contact.

Emageon standard service support is between the hours of 8 AM - 5 PM Central
time, Monday-Friday, excluding major holidays. Major Holidays include New Years
Day, Memorial Day, Independence Day, Labor Day, Thanksgiving Day, the day after
Thanksgiving, Christmas Eve, Christmas Day and New Years Eve. Emergency
telephone support will be available after standard hours, on weekends and
holidays, seven days a week. Emergency response times will target * * * or less
from first call for all other levels. * * *.

Emageon service engineers will provide remote support for the SYSTEM via
telephone and virtual private networks. The assigned service engineer will
provide timely and periodic feedback to Customer regarding the progress being
made in resolving the issue. As determined by Emageon, Emageon will provide
on-site support to resolve service issues. Once Emageon determines that on-site
support is required, Emageon will use its best efforts to place a qualified
individual on-site within * * *.

Upon notification, Emageon is responsible for any errors in the Emageon
Software. To the extent that an error is the result of third party Hardware or
Software, Emageon will use it's best efforts to resolve the issue. If the issue
is determined to be caused by the Customer, additional fees may apply at the
Professional Service Rates.

EMAGEON SUPPORT AND ESCALATION PROCEDURES

Support.

Upon receipt of notice from Customer, Emageon shall implement the
Support/Escalation Procedures described herein to ensure that appropriate
Emageon attention is given to Customer requests for support.

Severity Level 4 - Critical Problems.

The System or a significant component of the System is experiencing problems
which: (i) cause it to stop completely;(ii) materially degrade performance such
that Customer operations are in jeopardy;. Emageon shall provide telephone
response by a qualified technician within the Initial Response Time for Severity
Level 4 - Critical Problems as defined below. Within the Initial Response Time,
qualified personnel shall work to resolve the problem or condition. Emageon
personnel shall continue to work diligently until the problem is resolved.
Emageon shall demonstrate to Customer its good faith and diligent initiation and
prosecution of corrective measures. Emageon shall document the notification of
the problem, the severity level, the relevant circumstances and symptoms, and
the steps taken to diagnose the problem. Emageon shall take all necessary steps,
in its sole discretion, to resolve the problem promptly, and shall document such
corrective actions. If the problem condition is not resolved within the Target
Resolution Timeframe, Emageon shall dispatch expert on-site assistance to
Customer within * * *, as reasonably required. The response times applicable to
Severity Level 4 - Critical Problems is as follows:

* * *

Severity Level 3 - Serious or High Impact Problems.

The System is experiencing problems that cause a serious or high impact to the
SYSTEM. These problems are never enough to limit the use of the entire System,
meaning workarounds exists (If the Technical Points of Contact are not satisfied
with the timeliness of a workaround, they may escalate the incident to a
Severity Level

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

4), but if the issue is not resolved within the Targeted Resolution time, it
would escalate to a Severity 4 - Critical Problem. Emageon shall provide
telephone response by a qualified technician within the Initial Response Time
for Severity Level 3 - Serious Problems as defined below. Within the Initial
Response Time, qualified personnel shall work to resolve the problem or
condition. Emageon personnel shall continue to work until the problem is
resolved. Emageon shall demonstrate to Customer its good faith and diligent
initiation and prosecution of corrective measures. Emageon shall document the
notification of the problem, the severity level, the relevant circumstances and
symptoms, and the steps taken to diagnose the problem. Emageon shall take all
necessary steps, in its sole discretion, to resolve the problem promptly, and
shall document such corrective actions. If the problem condition is not resolved
within the Target Resolution Timeframe, Emageon may, at its sole discretion,
dispatch expert on-site assistance to Customer. Mutually agreed upon temporary
fixes or workarounds, if available, will be implemented until a permanent
resolution is provided. The response times applicable to Severity Level 3 -
Serious Problems is as follows:

* * *

Severity Level 2 - Impaired or Medium Impact Problems.

The System is experiencing problems that cause minor applications, functions or
features to fail to operate. The problem is severe enough to limit the
usefulness of the affected part of the System, but does not hamper the rest of
the System's usefulness. Emageon shall provide telephone response by a qualified
technician within the Initial Response Time for Severity Level 2 - Impaired or
Medium Impact Problems as defined below. Mutually agreed upon temporary fixes or
workarounds, if available, will be implemented until a permanent resolution is
provided. If the problem has not been fully resolved within the Target
Resolution Time Frame as defined below, the issue will escalated to Severity 3 -
Serious Problem. The response time applicable to Severity Level 2 - Medium
Impact Problems is as follows:

* * *

Severity Level 1 - Minor or Low Impact Problems.

The System is experiencing problems that cause minor irritations but do not
inhibit the usefulness of the System or Products. Emageon shall evaluate and
prioritize the problem. Severity Level 1 -Low problems will be resolved as
mutually determined by both parties.

Conditions.

Conditions that apply to the problem resolution process are:

(a)      All response times will be achieved at a rate of no less than * * * of
         the time, as measured over no less than * * * period.

(b)      Software products which are not produced by Emageon, but are components
         of the System, will be handled in the same manner. However, time to
         resolve a problem may vary depending upon the response by that third
         party vendor. Under no circumstances will Emageon be responsible for
         penalties or liabilities as a result of third party software failure.

(c)      Customer may not revise any Initial Response Time or Target Resolution
         Timeframes; however, if the problem results in the interruption of
         Customer's business operations, Emageon will dispatch expert on-site
         assistance to Customer at Customer's request, provided this is the most
         expedient means to resolve the problem as determined by mutual
         agreement of both Customer and Emageon.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

<PAGE>

Emageon may revise the process and procedures by which it records, responds to
and resolves issues for Customer, provided such revisions provide general
improvements to either the speed or efficiency with which problems are
corrected.

ROUTINE MAINTENANCE

Emageon will perform remote SYSTEM verification tests on a regular basis to
monitor Hardware and Software performance and capacity.

SUPPORT AND SERVICE RATES OUTSIDE THE SCOPE OF THIS AGREEMENT

All service and support rates for services at Customer's request, and that are
outside the scope of this Agreement, will be billed at the Professional Services
Rates. In all cases, travel and lodging are billed separately.

<PAGE>

                                    EXHIBIT C

                                  TERM AND FEES

            SOFTWARE, SUPPORT & MAINTENANCE AND PROFESSIONAL SERVICES

         Ascension Health commits to execute site-specific Order Addendums
         covering the committed minimum software, support and maintenance and
         professional services fees indicated below no later than the following
         time periods shown below based on the pricing and terms included in
         this Exhibit C * * *.

                      Table 1C: Ascension Commitment Table

<TABLE>
<S>                       <C>
* * *                         6/30/06

Total                     $25,066,000
</TABLE>

         The pricing set forth in this Agreement is based upon a target of * * *
         average annual study volume being achieved by June 30, 2006.

         Sixty (60) days prior to the commitment dates listed above (see Table
         1C); Emageon will provide to Customer documentation that compares the
         total of the Order Addendums that have been executed at that time to
         the commitment listed in Table 1C. Customer may use the aforementioned
         sixty (60) day period to cure the committed amounts described in Table
         1C.

         The study volume and fee commitments listed in Table 1C above are in
         part based on the deployment of the Emageon SYSTEM in * * * Terms and
         fees associated with added or substituted Facilities will be computed
         based on the terms and fees included in Exhibit C.1.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 26                      Confidential

<PAGE>

         Customer agrees to make payments to Emageon as described below upon
         execution of each Order Addendum by the ministries.

         * * *

         THIRD PARTY HARDWARE:

         If the Customer acquires Hardware from Emageon, Customer shall pay
         Emageon for the Hardware as follows:

         -        * * * of the Hardware fees shall be invoiced on the date the
                  Hardware is delivered, and the invoice shall be due and
                  payable within ten (10) business days.

         -        * * * of the Hardware fees shall be invoiced upon acceptance
                  of the Hardware by the Licensee, and the invoice shall be due
                  and payable within ten (10) business days.

         -        In the event of a partial Hardware shipment and upon mutual
                  agreement by the parties, Licensor may invoice Licensee on
                  that partial shipment. Provided, however, that the amount of
                  this partial invoice shall be exclusively for the items
                  contained in that partial shipment.

         -        At the time Hardware is ordered by Emageon, Emageon shall
                  provide Ascension Health Treasury with a detailed listing of
                  ordered Hardware. Emageon shall provide Ascension Health
                  Treasury with copies of all Hardware invoices for each
                  Facility and Emageon shall also provide, as an attachment to
                  the invoice, the details of what has been delivered to the
                  Facility.

         -        All Hardware, which is unpackaged, shall be considered "used
                  hardware" and shall not be returned unless such Hardware has
                  failed Hardware Installation Acceptance.

         THIRD PARTY VENDED SERVICES:

         -        Shall be due monthly beginning at Installation Acceptance

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 27                     Confidential

<PAGE>

                                   EXHIBIT C.1

                             TERM AND FEES - DETAILS

SPECIAL PRICING

The following Special Pricing shall apply to all Ascension Health Ministries
contracting under the Ascension and Emageon Enterprise Agreement.

           EMAGEON ULTRASTRUCTURE (ARCHIVE AND DISTRIBUTION) SOFTWARE

Ultrastructure Software is currently priced on a "per study" and total volume
basis. The projected volumes as set forth in Attachment C of the individual
Facility supplement are used to calculate the Archive and Distribution Software
Fees for each Facility. The Ascension price reflects a per tier discount that
ranges from * * * of the Standard Price.

         TABLE1: ULTRASTRUCTURE - LICENSE FEE PRICING CALCULATION TABLE

<TABLE>
<CAPTION>
AVERAGE ANNUAL STUDY VOLUME   STANDARD PRICE    * * *
---------------------------   --------------    -----
<S>                           <C>               <C>
       10,000-14,999          $         3.95    * * *
       15,000-19,999          $         3.16    * * *
       20,000-24,999          $         2.80    * * *
       25,000-32,499          $         2.75    * * *
       32,500-39,999          $         2.54    * * *
       40,000-47,499          $         2.31    * * *
       47,500-54,999          $         2.10    * * *
       55,000-64,999          $         2.00    * * *
       65,000-74,999          $         1.94    * * *
       75,000-89,999          $         1.81    * * *
      90,000-104,999          $         1.70    * * *
      105,000-174,999         $         1.57    * * *
      175,000-264,999         $         1.25    * * *
      265,000-374,999         $         0.98    * * *
      375,000-504,999         $         0.88    * * *
         505,000+             $         0.76    * * *
</TABLE>

    * * * ANNUAL MAINTENANCE FEES*

*     To commence on the first anniversary of the date of Installation
Acceptance.

ULTRASTRUCTURE SOFTWARE INCLUDES THE FOLLOWING:

         1.       Emageon Enterprise DICOM Storage & Archive Manager Software

         2.       Emageon Enterprise Integration Software (price included with
                  HL7 & MWL)

         3.       Emageon Intelligent Content Distribution Manager

         4.       Emageon High-Availability (HA) Software

         5.       Modality Worklist Manager

         6.       HL7 Reliable Delivery Manager (Reliable Store and Forward)

         7.       JPEG 2000 DICOM Transfer Syntax Support

         8.       Primary Image Server Software (runs on Emageon Linux Servers)

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 28                      Confidential

<PAGE>

TO CALCULATE THE UPFRONT PERPETUAL LICENSE FEE FOR THIS PURCHASE:

STEP 1: Divide total study volume over five years by 5 to get an average annual
study volume (Example: 1,000,000 total studies over 5 years / 5 years = 200,000
average studies per year)

STEP 2: Using the average annual study volume locate the appropriate tier in
Table 1 (Example: * * *)

STEP 3: Multiply the tier rate in Table 1 by the total number of studies over 5
years to give you the total Emageon Ultrastructure perpetual software license
cost (Example: * * *)

TO CALCULATE THE ANNUAL SUPPORT AND MAINTENANCE FEE FOR THIS PERPETUAL LICENSE:

The Annual Support and Maintenance fee shall be calculated by multiplying the
perpetual license fee by * * *. After the first year of Annual Support and
Maintenance Fees, the Annual Support and Maintenance fees may be increased to
reflect the annual percentage increase in the CPI.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 29                      Confidential

<PAGE>

                 EMAGEON ENTERPRISE DICOM CACHE MANAGER SOFTWARE

Emageon Enterprise DICOM Cache Manager Software is currently priced on a "per
study" and total volume basis. The projected volumes as set forth in Attachment
C of the Order Addendum are used to calculate the Archive and Distribution
Software Fees for each Facility. The Ascension price reflects a per tier
discount that ranges from * * * of the Standard Price.

       TABLE1A: ULTRASTRUCTURE - DICOM CACHE MANAGER - LICENSE FEE PRICING
                                CALCULATION TABLE

<TABLE>
<CAPTION>
AVERAGE ANNUAL STUDY VOLUME   STANDARD PRICE    * * *
---------------------------   --------------    -----
<S>                           <C>               <C>
       10,000-14,999               $1.97        * * *
       15,000-19,999               $1.58        * * *
       20,000-24,999               $1.40        * * *
       25,000-32,499               $1.38        * * *
       32,500-39,999               $1.27        * * *
       40,000-47,499               $1.15        * * *
       47,500-54,999               $1.05        * * *
       55,000-64,999               $1.00        * * *
       65,000-74,999               $0.97        * * *
       75,000-89,999               $0.91        * * *
      90,000-104,999               $0.85        * * *
      105,000-174,999              $0.78        * * *
      175,000-264,999              $0.63        * * *
      265,000-374,999              $0.51        * * *
      375,000-504,999              $0.44        * * *
         505,000+                  $0.38        * * *
</TABLE>

  * * * ANNUAL MAINTENANCE FEES*

* To commence on the first anniversary of the date of Installation Acceptance.

Emageon Enterprise DICOM Cache Manager Software supports all features of the
Emageon Enterprise DICOM Archive Manager Software and includes the following:

         1.   Serves as a local access point for a remote archive
                  May extend access from imaging center to hospital
                  May extend access from hospital to data center

         2.   Addresses distributed archiving environments
                  Provides the benefits of a centralized archiving solution
                  Provides performance of a local, dedicated archive
                  Provides local access in the event of WAN failure
                  Caches recently acquired / retrieved information locally
                  Reduces WAN bandwidth requirements / telecom costs

         3.   Proxy Service
                  Provides transparent access to remote information
                  Provides a full view and access to the enterprise archive
                  subsystem
                  Includes access to Legacy archives on the network

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 30                      Confidential

<PAGE>

         4.   Deletor Strategy Services
                  Least Recently Used (LRU)
                  Least Recently Written (LRW)
                  No Deletion Strategy
                  Study Deletion Veto Strategy
                  High/Low Water Mark thresholds

         5.   Extends capabilities of the Enterprise DICOM Archive Manager
              Software
         6.   Transparent access to all data (location transparency)

                          EMAGEON ULTRAVISUAL SOFTWARE

         Advanced Visualization tools are currently priced on a "concurrent
         user" basis. The Emageon Advanced Visualization Software perpetual
         license fees for Diagnostic and Clinical Workstation software at each
         Facility shall be calculated by multiplying the number of concurrent
         users for the respective type of workstation as set forth in Attachment
         B of the individual Order Addendum by the appropriate Emageon Advanced
         Visualization Software fee set forth below. The Emageon Advanced
         Visualization Software perpetual license fees as set forth below
         reflect a * * * discount from list price. If a Facility wishes to add
         concurrent users after the initial term has begun, the associated fees
         must be paid up-front.

         1.       * * *

                   ULTRAVISUAL ANNUAL SERVICE AND SUPPORT FEE

         Annual Service and Support fee is * * * of the Discounted License Fee
         for the Ultravisual Software. The Annual Service and Support fee shall
         commence on the first anniversary of the date of Installation
         Acceptance.

                  INSTALLATION AND ADOPTION SUCCESS MANAGEMENT

         Implementation and Adoption Success service fees are currently priced
         as a one time charge. These fees are set forth below in Table 1B of
         this Exhibit C. * * *.

         Computed Radiography (CR) implementation will require additional
         charges.

         1.       TECHNICAL IMPLEMENTATION FOR ARCHIVE AND DISTRIBUTION
                  INFRASTRUCTURE

                  (Price per Archive Storage Manager as set forth in Attachment
                  B of the individual site supplement)

         2.       TECHNICAL IMPLEMENTATION FOR CACHE ARCHIVE AND DISTRIBUTION
                  UNIT

                  (Price per Facility Image Cache as set forth in Attachment B
                  of the individual site supplement)

         3.       TECHNICAL IMPLEMENTATION FOR PRIMARY IMAGE SERVER SOFTWARE

                  (Price per facility)

         4.       STANDARD ASCENSION ADOPTION SUCCESS MANAGEMENT IMPLEMENTATION

                  (Price per facility and duties of both parties as set forth in
                  Exhibit G)

         5.       MODALITY INTEGRATION FEE

                  (Price per modality)

                        TOTAL ACCOUNTABILITY SERVICE FEE

         Emageon shall provide Total Accountability Services as defined in
         Section 1.29 of this Agreement. These fees are set forth below in Table
         1B of this Exhibit C. * * *.

         1.       EMAGEON TOTAL ACCOUNTABILITY SERVICE
                  (Price per facility per year)

                             PACS ADMINISTRATOR FEE

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 31                      Confidential

<PAGE>

         Emageon shall provide, at Customer's option, PACS Administrator(s) to
         provide the services as set forth in Exhibit H. The PACS Administrator
         Fees are set forth below in Table 1B of this Exhibit C. The fees for
         the PACS Administrator may be adjusted by mutual agreement to reflect
         the prevailing market rate for such services.

         1.       ON-SITE PACS ADMINISTRATOR ANNUAL CHARGE
                  (Price per PACS Administrator)

         If Customer chooses to provide their own PACS Administrator, then
         Customer agrees to send their PACS Administrator through Emageon's PACS
         Administrator training and certification process. Customer shall be
         responsible for their travel related expenses.

         * * *

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 32                      Confidential

<PAGE>

                          EMAGEON PROFESSIONAL SERVICES

         Emageon Professional Services are currently priced on a "per study
         tier" and unit basis. The projected volumes as set forth in Attachment
         C of the individual Order Addendum are used to calculate the
         appropriate per study tier and the applicable Professional Services
         Fees for each Facility. The prices listed below reflect discounts that
         ranges from * * * of the Standard Price.

         EXPLANATION OF PRICES LISTED IN TABLE 1B:

         ARCHIVE IMPLEMENTATION FEE (Price per Archive Storage Manager as set
         forth in Attachment B of the individual Order Addendum)
         CACHE IMPLEMENTATION FEE (Price per Facility Image Cache as set forth
         in Attachment B of the individual Order Addendum)
         IMAGE SERVER IMPLEMENTATION FEE (Price per facility)
         ADOPTION SUCCESS MANAGEMENT FEE (Price per facility and duties of both
         parties as set forth in Exhibit G)
         MODALITY INTEGRATION FEE (Price per modality)
         TOTAL ACCOUNTABILITY FEE (Price per facility per year)
         PACS ADMINISTRATION FEE (Price per PACS Administrator per year)

        TABLE 1B - ASCENSION PROFESSIONAL SERVICES - PER TIER PRICE TABLE

<TABLE>
<CAPTION>
Average Annual      Archive             Cache           Image Server    Adoption Success
 Study Volume  Implementation Fee Implementation Fee Implementation Fee  Management Fee
-------------- ------------------ ------------------ ------------------ ----------------
<S>            <C>                <C>                <C>                <C>
     * * *           * * *               * * *             * * *              * * *

<CAPTION>
   Modality          Total         PACS Admin.
Integration Fee Accountability Fee     Fee
--------------- ------------------ -----------
<C>             <C>                <C>
     * * *           * * *           * * *
</TABLE>

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 33                      Confidential

<PAGE>

                    THIRD PARTY HARDWARE AND VENDED SERVICES

         Emageon resells hardware (i.e., servers, storage, computed radiography
         devices, DICOM conversion boxes) and Vended Services and Third Party
         Software to support Emageon Software. Emageon will price all Hardware
         and Vended Services to Ascension Ministries at a * * * markup to
         Emageon's cost. Customer may acquire IBM and other hardware from a
         third party; provided, however, that the hardware purchased must be in
         accordance with Emageon specifications for warranty and service
         purposes. Furthermore, Customer agrees to grant Emageon a right to bid
         on purchases of PACS Hardware and Vended Service to be purchased by
         Committed Facilities as defined herein on or before * * *. For purposes
         of this paragraph, Committed Facilities means any Facilities that are:
         (i) part of the following Ascension Ministries: * * *; and (ii) any
         Facility that is listed in an executed Order Addendum.

                                 FUTURE PRODUCTS

         The contents of the Emageon Software as defined above, represent the
         full functionality of the Emageon Software being sold to Customer under
         this Agreement. Notwithstanding, System Upgrades and Updates as defined
         in this Agreement, and covered under the Software Support and
         Maintenance fees, the parties agree that any future, new product
         offerings are not covered under this Agreement and will be sold
         separately and then negotiated rates.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 34                      Confidential

<PAGE>

                                    EXHIBIT D

                          BUSINESS ASSOCIATE AGREEMENT

This Business Associate Agreement ("BAA") is entered into as of May 5, 2004 in
connection with the Managed Use Agreement (the "Agreement") by and between
Emageon UV, Inc. ("Business Associate") and Ascension Health and its Ascension
Affiliates ("Covered Entity").

WHEREAS, the Agreement requires Business Associate to have access to and/or to
collect or create Protected Health Information ("PHI") in order to carry out
Business Associate's functions on behalf of Covered Entity.

WHEREAS, Covered Entity and Business Associate intend to protect the privacy and
provide for the security of PHI disclosed, collected or created by Business
Associate in connection with the Agreement in compliance with the Health
Insurance Portability and Accountability Act of 1996, Public Law 104-91
("HIPAA") and the regulations promulgated thereunder, including, without
limitation, the regulations codified at 45 CFR Parts 160 and 164 (the "Privacy
Rule"), 45 CFR Parts 160, 162 and 164 ("Security Rule"), and other applicable
laws.

NOW THEREFORE, in consideration of the mutual promises contained herein and the
exchange of PHI pursuant to this Business Associate Agreement, the parties agree
as follows:

1. DEFINITIONS

1.1      GENERAL RULE. Capitalized terms not otherwise defined in this BAA shall
         have the same meaning as those terms in the Privacy Rule and Security
         Rule.

1.2      HIPAA means the Health Insurance Portability & Accountability Act of
         1996, P.L. 104-91.

1.3      HIPAA REGULATIONS means the regulations promulgated under HIPAA by the
         U.S. Department of Health and Human Services, including the Privacy
         Rule and Security Rule.

1.4      PRIVACY RULE means the Standards for Privacy of Individually
         Identifiable Health Information, codified at 45 CFR parts 160 and 164,
         Subparts A and E, as currently in effect.

1.5      PROTECTED INFORMATION means Protected Health Information ("PHI")
         provided by Covered Entity to Business Associate, or created or
         received by Business Associate on Covered Entity's behalf.

1.6      SECURITY RULE means the Security Standards for the Protection of
         Electronic Protected Health Information, codified at 45 CFR Parts 160,
         162 and 164, as currently in effect.

2. BUSINESS ASSOCIATE OBLIGATIONS

2.1      Use and Disclosure of Protected Health Information. Business Associate
will: (a) use and disclose all PHI only as permitted or required to perform its
obligations under the Agreement, including this BAA, or as required by law; and
(b) will not use or further disclose any PHI in a manner that would violate
HIPAA, if such use or further disclosure was made by Covered Entity.

2.2      Disclosures to Agents and Subcontractors. Business Associate shall
ensure that any agent or subcontractor to whom it provides PHI agrees in writing
to the same terms set forth herein regarding the Use and Disclosure of PHI,
including, but not limited to, implementation of safeguards, notice of
prohibited Use or Disclosure, mitigation of harmful effects, responses to
requests for access and amendment, and a term permitting immediate termination
of the agent's or subcontractor's agreement with Business Associate for improper
Use or Disclosure of Protected Information. Business Associate shall terminate
its agreement with any agent or subcontractor to whom it provides PHI if such
agent or subcontractor fails to abide by any material term of such agreement.

2.3      Permitted Uses of Protected Health Information. Business Associate may
use PHI only as follows: (a) for the proper management and administration of
Business Associate; (b) to provide the Services described in or required by

Emageon Enterprise Agreement           Page 35                      Confidential

<PAGE>

the Agreement and any additional or other services described in any addendum or
modification to the Agreement agreed to by Business Associate and Covered
Entity; (c) to carry out legal responsibilities of Business Associate; or (d) to
report violations of law to appropriate Federal and State authorities consistent
with 45 C.F.R. Section 164.502(j)(l).

2.4      Permitted Disclosures of Protected Health Information. Business
Associate may disclose PHI only as follows: (a) to authorized persons designated
by Covered Entity in writing; (b) to the patient that is the subject of the
information pursuant to procedures determined by Covered Entity and in
accordance with applicable law; (c) to a physician or other health care
professional authorized by Covered Entity in writing to access the information;
(d) to other persons as expressly requested in writing by Covered Entity and in
accordance with applicable law; (e) to persons under Business Associate's direct
control as necessary to satisfy Business Associate's obligations under the
Agreement; (f) to other agents and subcontractors of Business Associate only as
necessary to satisfy Business Associate's obligations under this Agreement and
only, if and to the extent, those agents and subcontractors agree to the same
restrictions and conditions on the use and disclosure of PHI that apply to
Business Associate through this BAA; (g) as required by law; and (h) for
Business Associate's proper management and administration or to carry out its
legal obligations if: (1) the disclosure is required by law or (2) Business
Associate obtains reasonable assurances from the person to whom the information
is disclosed that it will be held confidentially and used or further disclosed
only as required by law or for the purpose for which it was disclosed to
Business Associate and the person notifies Business Associate of any instances
of which it is aware in which the confidentiality of the information has been
breached.

2.5      Disclosures Required by Law. If a disclosure of PHI is required by law,
including pursuant to a request from a state or federal government agency or
pursuant to a subpoena or a court order in a judicial proceeding, Business
Associate shall promptly notify Covered Entity of such request, and Covered
Entity shall ___________.

2.6      Safeguards; Mitigation. Business Associate shall use appropriate
safeguards to prevent the use or disclosure of PHI other than as permitted or
required by the Agreement and this BAA or as permitted or required by law.
Business Associate agrees to mitigate, to the extent practicable, any harmful
effect that is known to Business Associate of use or disclosure of PHI by
Business Associate in violation of the requirements of this BAA.

2.7      Reports of Unauthorized Use or Disclosure. Business Associate shall
report in writing, within forty-eight (48) hours, to Covered Entity any use or
disclosure of PHI not provided for by this BAA of which it becomes aware.

2.8      Availability of PHI. Business Associate will make all PHI available to
Covered Entity and otherwise cooperate with Covered Entity to the extent
necessary for Covered Entity to comply with its obligations under 45 C.F.R.
Sections 164.524-528, including providing patients access to medical records, an
opportunity to amend incorrect information and an accounting of disclosures of
PHI. Business Associate further agrees to make its internal practices, books and
records, including policies and procedures and Confidential Information,
relating to the use and disclosure of PHI available to the Secretary of Health
and Human Services in a time and manner designated by the Secretary of Health
and Human Services, if necessary, for the purpose of determining Covered
Entity's compliance with HIPAA.

2.9      Electronic Protected Health Information. To the extent that Business
Associate creates, receives, maintains or transmits Electronic Protected Health
Information on behalf of Covered Entity on or after April 21, 2005, Business
Associate agrees to:

A.       Implement Administrative, Physical and Technical Safeguards that
         reasonably and appropriately protect the confidentiality, integrity and
         availability of the Electronic Protected Health Information;

B.       Ensure that any agent, including a subcontractor, to whom it provides
         Electronic Protected Health Information agrees to implement reasonable
         and appropriate safeguards to protect it; and

C.       Report to Covered Entity any Security Incident of which Business
         Associate becomes aware.

2.10     Limitations and Restrictions. To the extent that Covered Entity
notifies Business Associate of any limitations in its notice of privacy
practices under Section 3.2(A) herein; any changes in or revocations of
permission under Section 3.2(B) herein; or any restrictions under Section 3.2(C)
herein; Business Associate shall comply with such limitations, revocations or
restrictions, as applicable.

3. COVERED ENTITY OBLIGATIONS

Emageon Enterprise Agreement           Page 36                      Confidential

<PAGE>

3.1      Requests. Subject to uses and disclosures permitted under this BAA,
Covered Entity shall not request Business Associate to use or disclose PHI in
any manner that would not be permissible under HIPAA if done by Covered Entity.

3.2      Required Notices.

A.       Covered Entity shall notify Business Associate of, and specifically
         identify, any limitations in its notice of privacy practices in
         accordance with 45 C.F.R. Section 164.520, to the extent that such
         limitations impose restrictions beyond those generally applicable under
         HIPAA and may affect Business Associate's use or disclosure of PHI.

B.       Covered Entity shall notify Business Associate of any changes in, or
         revocation of, permission by an Individual to use or disclose PHI, to
         the extent that such changes may affect Business Associate's use or
         disclosure of PHI.

C.       Covered Entity shall notify Business Associate of any restriction to
         the use or disclosure of PHI that Covered Entity has agreed to in
         accordance with 45 C.F.R. Section 164.522, to the extent that such
         restriction may affect Business Associate's use or disclosure of PHI.

4. TERM AND TERMINATION

4.1      Term. This BAA shall commence as of the Effective Date and shall
continue in effect so long as the Underlying Agreement is in effect. Upon
termination of the Underlying Agreement for any reason, this BAA shall
automatically terminate, without action of the parties. Notwithstanding the
first sentence of this Section 4.1, if either party determines that this BAA is
no longer required, then either party may terminate this BAA upon written notice
to the other, and the Underlying Agreement shall thereafter continue in full
force and effect.

4.2      Termination for Cause. If Covered Entity determines that Business
Associate, or any of its agents or subcontractors, has breached any material
provision of this BAA, Covered Entity may terminate the Agreement if Business
Associate fails to cure a default or breach of a material term of this BAA
within fourteen (14) days after or, at Covered Entity's sole discretion, it
receives written notice of such default or breach from Covered Entity. If
neither termination nor cure is feasible, Covered Entity may report the
violation, if any, to the Secretary of Health and Human Services.

4.3      Effect of Termination. Except as provided herein, upon termination of
the Agreement or of this BAA for any reason (and if Business Associate and
Covered Entity do not enter into any comparable successor agreement or BAA),
Business Associate shall return or destroy all PHI, including Confidential
Information that is in the possession of subcontractors or agents of Business
Associate, and Business Associate shall retain no copies of the PHI. In the
event that returning or destroying the PHI is infeasible, Business Associate
shall provide to Covered Entity notification of the conditions that make return
or destruction infeasible and shall extend the protections of this BAA to such
PHI and limit further uses and disclosures of such PHI to those purposes that
make the return or destruction infeasible, for so long as Business Associate
maintains such Confidential Information.

5. MISCELLANEOUS

5.1      No Third Party Beneficiary. The provisions and covenants set forth in
this BAA are expressly entered into only by and between Business Associate and
Covered Entity and are intended only for their benefit. Neither Business
Associate nor Covered Entity intends to create or establish any third party
beneficiary status or right (or the equivalent thereof) in any other third
party, and no such third party shall have any right to enforce or enjoy any
benefit created or established by the provisions and covenants in this BAA.

5.2      Regulatory References. A reference in this BAA to a section in the Code
of Federal Regulations means the section as in effect or as amended, and for
which compliance is required.

5.3      Governing Law. This BAA shall be construed in accordance with the laws
of the State of Missouri.

5.4      Amendment. The Parties agree to take such action as is necessary to
amend this BAA from time to time as is necessary for Covered Entity to comply
with the requirements of HIPAA.

5.5      Interpretation. Any ambiguity in this BAA shall be resolved in favor of
a meaning that furthers the obligations to protect the privacy of the PHI in
accordance with the Privacy Rule or Security Rule, as applicable.

Emageon Enterprise Agreement           Page 37                      Confidential

<PAGE>

5.6      Counterparts. This BAA and any exhibits hereto may be executed in one
or more counterparts; each counterpart shall be deemed an original.

5.7      Notices. All notices required or permitted to be given under this BAA
shall be in writing and shall be sufficient in all respects if delivered
personally, by nationally recognized overnight delivery service, or by
registered or certified mail, postage prepaid, addressed as follows:

If to Emageon: Emageon, Inc.           If to Covered Entity: Ascension Health
               1200 Corporate Drive                          4600 Edmundson Road
               Suite 400                                     St. Louis MO. 63134
               Birmingham, AL 35242                          ATTN:
               ATTN: CFO

Notice shall be deemed to have been delivered and given for all purposes (i) on
the delivery date if delivered personally to the party to whom the same is
directed; (ii) one business day after deposit with a commercial overnight
carrier, with written verification of receipt, or (iii) five business days after
the mailing date whether or not actually received, if sent by U.S. certified
mail.

IN WITNESS WHEREOF, the parties hereto have duly executed this Business
Associate Agreement as of the date set forth below.

Business Associate                        Covered Entity
Emageon UV, Inc.                          Ascension Health

By: /s/ W. Randall Pittman                By: /s/ Sherry Browne
    ----------------------                    ----------------------------------

Name: W. Randall Pittman                  Name: Sherry Browne
     ---------------------                      --------------------------------

Title: CFO                                Title: SVP & Chief Information Officer
       -------------------                       -------------------------------

Date: 5/6/04                              Date: May 5, 2004
      --------------------                      --------------------------------

Emageon Enterprise Agreement           Page 38                      Confidential

<PAGE>

                                    EXHIBIT E
                                EMAGEON UV, INC.
                           CORPORATE TRAVEL GUIDELINES

                                  INTRODUCTION

Emageon employees may be required to travel on official Company business from
time to time. Emageon will reimburse employees, within prescribed limitations,
for all necessary and actual travel expenses incurred while traveling on Company
business.

The Corporate Travel Guidelines, presented here, should facilitate the timely
reimbursement of employees for allowable travel expenses incurred during travel
on Company business. The guidelines address most common travel situations, but
they are not intended as a substitute for knowledge of existing Company policy
or IRS regulations.

Travel expenses may also be allowed as part of an employee relocation and
employee recruitment.

                               TRAVEL EXPENSE FORM

The Travel Expense Form is available as a general template for electronic entry
and presentation of travel and related expenses. The Form is designed to provide
the minimum information required to support expenditures incurred by employees.
The report accomplishes several objectives.

         -        First, it provides employees responsible for approving these
                  expenses with the necessary details to perform the task.

         -        Second, it provides Finance personnel with the information
                  necessary to account for these expenses consistent with
                  Company policies and IRS regulations.

         -        Third, it enables Finance to reconcile amounts reported by
                  employees as Company-paid items with invoices received from
                  vendors for such services.

                    TRAVEL EXPENSE PROCESSING & REIMBURSEMENT

Each employee is required to promptly submit expense reports that are complete,
timely and with appropriate receipts and documentation attached. Approval by the
employee's Department Head serves several purposes:

         -        First, it confirms that the purpose of the trip is to conduct
                  company business.

         -        Second, the charges are reasonable and appropriate under the
                  circumstances and consistent with Company policies.

         -        Third, the required documentation and receipts are attached.

With few exceptions, Finance will arrange for travel and related expenses to be
reimbursed within a week of submission of an approved expense report.

AIR TRAVEL

There are certain guidelines that apply to Air Travel.

         1.       The least expensive routing should always be sought. Book your
                  travel as far in advance as possible to qualify for more
                  economical prices.

         2.       Southwest Airlines is the preferred airline for travel to and
                  from Birmingham and other cities serviced by Southwest.

         3.       Coach class will be used for all flights, except in those
                  instances where the customer has contractually agreed to
                  reimburse the company for an upgrade to higher class.

         4.       Employees are not authorized to use personal frequent flyer
                  miles and charge the Company for the corresponding value.

         5.       The company does not provide memberships in airline travel
                  clubs at company expense.

         6.       The only acceptable receipt for airline travel fares is the
                  Passenger Receipt. Itineraries, boarding passes, credit card
                  receipts, etc. are not acceptable for reimbursement.

         7.       Employees are encouraged to use e-ticket services offered by
                  most airlines. These airlines email or provide printed
                  receipts and itineraries.

         8.       In the event the Passenger Receipt is misplaced, a copy is
                  available through the travel agency of record.

Emageon Enterprise Agreement           Page 39                      Confidential

<PAGE>

USE OF RENTAL & PERSONAL VEHICLES

It may be necessary for an employee(s) to utilize a vehicle rented from a
commercial agency such as Hertz or National or their personal vehicle while on
Company business. Employees will be reimbursed for the use of their privately
owned vehicle at the IRS recommended mileage rate. Reimbursement for the use of
rental vehicles will be made in full as long as the vehicle was used exclusively
for Company business.

There are certain guidelines that apply to the use of Leased or Privately Owned
Vehicles.

1.       Vehicles should be sized appropriately for the intended purpose.
         Moderate size autos are encouraged.

2.       When at all possible, fill up auto rentals with gas before returning
         to the rental agency.

3.       If you pay for auto rental charges by other than credit card, you are
         subjecting yourself and the Company to liability for injury to
         yourself, passengers in your vehicle or any other vehicle(s) involved,
         pedestrians, and the physical damage to other vehicles and property.

4.       The use of a credit card when renting a vehicle achieves two purposes.
         You have the added insurance coverage the credit card company offers a
         specified insurance coverage in the event of an accident this allows
         you to decline the optional insurance offered by the rental agency.

If an accident occurs involving a privately owned or rental vehicle being used
for Company business, the following actions should be taken:

         1.       The vehicle operator or some other reliable person should
                  immediately report the accident to local, county or state
                  police.

         2.       At the accident scene, statements should not be made to anyone
                  except law enforcement officers. It will be necessary to
                  discuss the accident with insurance company representatives.

         3.       If possible, obtain pertinent information of other parties
                  involved in the accident such as name, address, telephone
                  number(s), driver's license number, and insurance information
                  of other parties involved in the accident.

         4.       In case of an accident in which there are serious injuries or
                  death, immediately notify your Manager/Department Head of the
                  accident. If the employee is unable to do so, then the first
                  employee having knowledge of the accident should make the
                  notification. This information should be reported to the CEO,
                  the CFO and the InHouse Counsel as soon as possible.

         5.       A complete report of the accident should be provided to the
                  InHouse Counsel within 24 hours of the accident if possible.

Employees operating a leased or privately owned vehicle are responsible for
operating the vehicle in a safe and prudent manner and in accordance with all
applicable federal, state, and local traffic laws. Fines assessed for traffic
citations or other violations of applicable traffic laws are the responsibility
of the employee and are not reimbursable.

HOTEL ACCOMMODATIONS

Employees will be reimbursed for actual accommodation expense incurred,
including the state/local taxes applied thereto. The official receipt from the
establishment must be submitted with the Travel Expense Report Form.

         1.       Travelers are expected to arrange the lowest-cost reasonable
                  accommodations, such as the Hampton Inn.

         2.       Charges for room rental and associated taxes should be
                  categorized by day. Other charges included on the hotel bill
                  for meals, telephone, fax and other services should be
                  reported on the applicable day and in the appropriate line on
                  the Travel Expense Report Form.

         3.       Laundry costs are reimbursable on trips longer than 4 nights.

         4.       Hotel/motel pay movies are not reimbursable.

ENTERTAINMENT

The company recognizes that a certain amount of customer entertainment is a
reasonable and customary business expense.

         1.       Caution must be exercised when employees of federal, state and
                  local government regulatory bodies or agencies are present
                  when entertainment expenditures are involved as applicable
                  federal and state laws severely limit the amounts that can be
                  expended in such situations.

Emageon Enterprise Agreement           Page 40                      Confidential

<PAGE>

         2.       When it is proposed that the company pay for travel and
                  related expenses by non-employees, approval of the CEO and
                  President is required in advance.

         3.       All entertainment expense in excess of $25 must be supported
                  by a receipt. In addition, the individuals present, the nature
                  of the entertainment and an explanation provided in the
                  appropriate space on the expense report.

TRAVELER'S MEALS/BUSINESS MEALS

         1.       Employee meals are normally reimbursable only when away from
                  home on overnight travel.

         2.       Meals should be reported as breakfast, lunch or dinner on the
                  day incurred.

         3.       In general, lunch is the responsibility of the employee except
                  when traveling, or for a special occasion organized by the
                  company. In particular, luncheon expenses for meals involving
                  only employees who are in frequent contact with one another,
                  should be the responsibility of the individuals and not the
                  Company.

         4.       Receipts are required for any individual meal in excess of
                  $25; a credit card charge slip or cash register receipt are
                  acceptable but the names of the participants and the business
                  nature of the occasion must be indicated in the appropriate
                  space on the expense report.

         5.       Traveler's and business meals are subject to tax deductibility
                  limitation while Company meeting expense is a fully deductible
                  business expense. Therefore, it is important that your
                  expenditures are properly classified among these three
                  categories. The following are definitions of each of the three
                  expenses.

                           a.       Employee's Meals - Cost incurred by an
                                    employee for his/her meals while traveling
                                    on Company business.

                           b.       Business Meals - Report the cost of food or
                                    beverages for one or more participants
                                    (employees and non-employees) and the nature
                                    of the business discussion that ensued. The
                                    cost of the employee(s)' meal should be
                                    included with the other participants and
                                    reported as Business Meal/Entertainment. The
                                    reporting requirements for such situations
                                    are the same as for entertainment.

                           c.       Company Meeting - Normally the cost of
                                    meeting rooms, instruction materials and
                                    supplies, meals and refreshments that are
                                    incidental to a Company meeting will be
                                    handled by a Company representative who will
                                    make arrangements for their payment. The
                                    Company representative responsible for the
                                    arrangement is required to submit an expense
                                    report identifying the participants and the
                                    business purpose of the meeting. Individual
                                    employees are required to submit expense
                                    reports only if employee(s) incur travel
                                    expenses other than those provided as part
                                    of the proceedings. Normally, a Company
                                    meeting will only involve Company personnel,
                                    however when non-company personnel are
                                    present, their expenses should be reported
                                    separately.

TAXIS, TOLLS AND PARKING

         1.       The IRS (and the Company) requires receipts for taxi, airport
                  limo, bus, toll and parking charges.

POSTAGE, OFFICE SUPPLIES AND OTHER MISCELLANEOUS EXPENSES

         1.       The Expense Report form provides for travelers to report
                  office supplies and other miscellaneous expenses.

         2.       This feature is primarily intended for Sales Representatives
                  and other employees who reside outside of Birmingham and do
                  not have access to office supplies available at Emageon
                  office.

                              EXPENSE DOCUMENTATION

         1.       To comply with Internal Revenue Service documentation
                  requirements, receipts are required for all expenditures. In
                  the event a receipt is misplaced, a detailed note should be
                  included with your expense report.

Emageon Enterprise Agreement           Page 41                      Confidential

<PAGE>

                                    EXHIBIT F
                           PROJECT ACCEPTANCE PROCESS

  THIS IS A SAMPLE INSTALLATION ACCEPTANCE PROCESS (NOT ALL COMPONENTS OF THIS
       SAMPLE PLAN WILL BE APPLICABLE TO EVERY CUSTOMER. THIS DOCUMENT IS
                           INTENDED AS A SAMPLE ONLY.)

      The acceptance process is divided into three phases:

Hardware Installation Acceptance

Installation Acceptance

Transition to Service

HARDWARE INSTALLATION ACCEPTANCE

                  The Order Addendum shall provide the specific detail for each
                  Customer. Unless otherwise provided herein or in the Order
                  Addendum, the Hardware shall be deemed accepted by Customer
                  when Emageon certifies completion of installation of the
                  Hardware. Should Emageon be prevented from installing the
                  Hardware in accordance with the mutually agreed upon written
                  installation schedule due to Customer's inability to take
                  delivery, or begin installation of the Hardware, then the
                  Hardware shall be deemed installed and accepted fifteen (15)
                  days after the agreed upon written installation schedule.
                  Customer agrees to pay all fees associated with the Hardware
                  acceptance to Emageon at that time. Should Installation of the
                  Hardware be delayed solely due to the fault of the other
                  party, the delayed party may recover from the delaying party
                  actual expenses incurred as a direct result of such delay.."

                  Emageon will perform and document the results of the Hardware
                  Installation Acceptance in accordance with the attached sample
                  below or as defined in this Agreement, if different from the
                  example. The Customer point of contact will observe the
                  analyses and sign-off on each task upon successful completion.
                  In addition to any other testing or checklist required to
                  confirm that the System conforms to the System Specifications,
                  the parties shall confirm the presence of the functionality
                  described and evidenced with a checkmark below, and such
                  functionality shall be included within the definition of
                  "System Specifications":

* * *

SYSTEM INSTALLATION ACCEPTANCE

                  The Order Addendum shall provide the specific details for each
                  customer. However, the following provides an excerpt from the
                  Order Addendum related to System Installation Acceptance.

                  Emageon will perform and document the results of the System
                  Installation Acceptance in accordance with the attached sample
                  below or as defined in this Agreement, if different from the
                  example. The Customer point of contact will observe the
                  analyses and sign-off on each task upon successful completion.

* * *

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 42                      Confidential

<PAGE>

TRANSITION TO SERVICE

                  The final phase of the project is to transfer responsibility
                  for the Customer from Emageon Adoption Success Management (as
                  described in Exhibit G) to the Emageon Service Group. Since
                  the Emageon model demands that we earn our money every month,
                  the transition to Service is different in several ways. One
                  example is the Emageon Service Group utilizes a Continuous
                  Improvement Model. As part of the model, the implemented
                  system will be perpetually improved and upgraded to meet the
                  requirements as defined in the Customer contract.

                  During the implementation, every attempt is made to complete
                  open items related to system configuration, system
                  performance, training, etc. However, since open items will
                  usually exist, our model is designed for the Service the Group
                  to assume responsibility and manage open items, while
                  continually monitoring and improving the system.

                  The transition to Service begins during the ASM Integration
                  and Training phase. During this phase the Emageon Service team
                  will:

Conduct on site visits and perform equipment and workflow audits.

Become familiar with site layout and facilities

Meet the customer team

Monitor progress of project

Assist with Customer training

Validate remote monitoring and access capability

Verify site document is complete

                  As a part of the transition, ASM is responsible for completing
                  and transferring documented information related to the system
                  configuration, test results, and day-to-day operational
                  procedures as defined in the table below.

* * *

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 43                      Confidential

<PAGE>

                                    EXHIBIT G
                      ADOPTION SUCCESS MANAGEMENT SERVICES

Adoption Success Management (ASM) services, Emageon and related CUSTOMER
responsibilities are detailed below. Emageon and CUSTOMER agree to perform the
duties assigned to each of them, respectively, as set forth below.

OVERVIEW

ASM services are an Emageon developed, refined and tested methodology for
deploying Enterprise Image Management Systems (EIMS). ASM services may be
offered in conjunction with Emageon Implementation Services or may be an
"overlay" process to a 3rd party's implementation process. The service is
designed to be dynamic and configurable to an individual Facility's needs. The
ASM methodology utilizes skills in project management, change management,
clinical workflow and training with a focus on the applied principles of adult
learning.

The purpose of ASM services is to minimize the time required for an organization
to adopt an EIMS, maximize the effective value of an EIMS, and to mitigate the
organizational disruptions that may occur during a major information technology
implementation.

Emageon and CUSTOMER are jointly responsible for the success of the ASM project,
and for providing the necessary resources for the project.

* * *

CUSTOMER RESPONSIBILITIES

CUSTOMER shall:

-        Be Responsible for The Adoption of the EIMS

-        Provide Access To Necessary Personnel And Facilities Critical In The
         Facilitation Of The ASM Project

-        Provide Necessary Communications Support - Telephone, Internet Access,
         Etc

-        Insure CUSTOMER Provided Facilities, Information Systems And Modalities
         Are Prepared, Maintained And Operational For Integration Into The EIMS

-        Participate In ASM Meetings

-        Participate, at its own cost, in Development of Materials, Including
         But Not Limited To Marketing Materials, Training Guides, Communication
         Tools and Similarly Related Materials for Deployment and Adoption of
         The EIMS.

-        Provide A Dedicated ASM Project Coordinator To Support And Facilitate
         The ASM Project

-        Shall Bear and Pay All Costs Associated With The Production of
         Materials, Including But Not Limited To Marketing Materials, Training
         Guides, Communication Tools and Similarly Related Materials for
         Deployment and Adoption of The EIMS.

CUSTOMER Shall Make Personnel And Facilities Available According To A Mutually
Agreed Upon Schedule.

-------------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 44                      Confidential

<PAGE>

                                    EXHIBIT H
                       EMAGEON PACS ADMINISTRATOR SERVICES

Emageon PACS ADMINISTRATOR Services and related responsibilities are detailed
below by function.

GENERAL

Where specified in an Order Addendum, Emageon will provide a PACS Administrator
(PA) for the duration of the Agreement to perform the duties as defined below.
The PACS Administrator will report to Emageon, but have day to day operational
reporting to a designated Customer manager.

Assumptions and General Understandings between the Parties:

         -        Standard hours for PA(s) are from 8 am to 5 pm CST. After
                  hours support will be handled through pager communications.

         -        Workload for PA shall remain consistent with normal, industry
                  accepted workloads for a trained and reasonably skilled
                  individual performing these functions. Ratios to be used for
                  determining acceptable workload shall include number of
                  radiologists, number of studies performed annually, number of
                  diagnostic reading stations, after hours reading requirements
                  and system accessibility requirements.

         -        PA shall be mutually selected by both parties.

Customer Obligations

1.       Customer shall provide an adequate working space in or near the
         facilities requiring PA services from the PA.

2.       Customer shall provide the equipment necessary for the PA to perform
         the necessary functions of the PA position. This equipment includes, at
         a minimum, the following:

         a)       Telephone

         b)       Computer with access to the facility networks and Internet and
                  all necessary applications to perform the functions of PA

         c)       Pager for after hours on-call communications

         d)       Other tools and diagnostic equipment necessary for the
                  troubleshooting and repair of imaging equipment. Any third
                  party tools that modality vendors may require for
                  troubleshooting their products are the responsibility of the
                  Customer.

3.       Customer shall provide, during the entire term of the Agreement, a
         suitable "on-call" employee capable of performing the majority of the
         PA's routine tasks. This on-call employee will be responsible for
         managing the day to day operational duties during all hours when the PA
         is not scheduled, including, but not limited to, additional work
         shifts, vacation time, sick time, and scheduled Emageon Company
         holidays.

4.       Customer shall assign a manager for the purpose of assigning day to day
         operational duties to the PA.

Emageon Obligations

         1.       Emageon shall provide the recruiting, hiring and training of
                  all PA resources required for performing the PA functions.

         2.       Emageon will provide a computer for access to Emageon
                  documents and all other materials necessary for the
                  performance of the PA functions.

         3.       Emageon will nominate a Supervisor for the PA for overall
                  management, training and disciplinary actions.

         4.       Emageon will be solely responsible for PA's compensation and
                  benefits.

Emageon will utilize all tools necessary for the troubleshooting and repair of
its contracted components.

Selection of PACS Administrator

The minimum requirements for the qualifications of the PA are outlined herein.
Emageon will identify qualified candidates and conduct formal interviews. Upon
completion of the interview process, Emageon will provide no less than two
qualified PA applicants for Customer review. Customer will select the preferred
candidate, and Emageon will extend a formal offer for hire of this individual.
In the event the preferred candidate cannot be hired for any reason, Emageon
will extend a formal offer for hire to the second candidate. The PA will be
scheduled to begin employment within thirty (30) days prior to or immediately
following the scheduled commencement of the implementation process.

PACS Administrator Review Process

Emageon Enterprise Agreement           Page 45                      Confidential

<PAGE>

The PA will be reviewed for performance on a quarterly basis by the designated
Customer manager and will be reviewed once annually by both Customer and Emageon
for performance. All Designated Customer manager reviews will be sent to the
Emageon Human Resources Specialist within thirty (30) days of the end of the
evaluation period. Criteria for the performance review shall be mutually agreed
upon by Customer and Emageon. Any disciplinary action shall be at the sole
discretion of Emageon.

Disciplinary Action

If at any time, the designated Customer manager feels that the PA has engaged in
any violation of Emageon or Customer policy which warrants disciplinary action,
the designated Customer manager must notify the Emageon Human Resources
Specialist within three (3) business days of the actual violation or of becoming
aware of the violation by way of written correspondence outlining the details of
the violation. Any disciplinary action shall be at the sole discretion of
Emageon.

Termination of PACS Administrator

The PA may be terminated by Emageon for any reason by which Customer may
terminate any employee of the Customer, or for any reason by which Emageon may
terminate any Emageon employee, including failure to perform in accordance with
agreed criteria. A copy of Customer's employment terms and conditions must be
provided to Emageon upon execution of this Agreement.

Replacement of PACS Administrator

In the event of voluntary or involuntary termination of PA, Emageon shall
provide, within five (5) business days, a temporary replacement for the PA.
Emageon will provide, within 60 days, a permanent replacement for the terminated
PA, and will provide the required education and training necessary for the
replacement PA to perform the duties as identified below.

Grievance Policy

In the event the PA has an employment-related issue or conflict that cannot be
resolved through 1) discussions with the designated Customer manager and 2)
discussions with the appropriate Emageon manager, the Grievance Policy as set
forth in the Emageon, Inc. Employee Manual shall be followed.

Travel Policy

All travel, lodging and related expenses of the PA incurred on business
transacted at the request of the Customer will be submitted to Customer for
reimbursement according to the Customer's travel reimbursement policy. If
Customer does not have a published travel reimbursement policy, then the Emageon
policy shall prevail.

PACS ADMINISTRATOR FUNCTIONS

<TABLE>
<CAPTION>
      PACS Administrator
          Functions                               Description
-------------------------------     --------------------------------------------
<S>                                 <C>
Primary Communication               Coordination and communication throughout
                                    the project integration to all project
                                    players for Emageon and customer.

System Installation                 Management of RIS/ PACS implementation
                                    process including order review, project
                                    planning, resource scheduling and
                                    coordination, Facility specific system
                                    configuration design, equipment scheduling.

Facilities Readiness and            Assure that the customer site complies with
Preparation                         Emageon specified power, heat, dimension,
                                    and network requirements.  Monitor site
                                    to assure site readiness, scheduled delivery
                                    dates, and installation readiness.

Daily Operations                    Manage day-to-day operation of PACS
                                    equipment including image workflow,
                                    archiving, routing, pre-fetching, correcting
                                    broken studies, editing patient demographics,
                                    HIS/RIS interface
</TABLE>

Emageon Enterprise Agreement           Page 46                      Confidential

<PAGE>

<TABLE>
<CAPTION>
      PACS Administrator
          Functions                               Description
-------------------------------     --------------------------------------------
<S>                                 <C>
Support, troubleshooting
and issue resolution                Document and communicate specific issues
                                    identified by clinical users with respect to
                                    Service issues, updates, progress and
                                    resolution. Escalate and be an advocate for
                                    customer support, issues and problems.

Disaster Preparedness,
Failure Correction and Recovery     Initiate switchover to system and/or
                                    component backup procedures as necessary and
                                    report any system or component failures to
                                    Emageon.

                                    Perform daily, weekly, and monthly routine
                                    maintenance procedures as required. Perform
                                    backup/ disaster recovery procedures,
                                    including off-site storage of tapes as
                                    required.

Training and Internal PACS          Support application programmers and end-user
Communications                      groups and communicate any requests for
                                    moves, additions, and changes to the Emageon
                                    system.

                                    Monitor clinical workflow procedures and
                                    make recommendations for improvement.
                                    Conduct system/ component training.

                                    Serve as PACS liaison to hospital departments.
</TABLE>

PACS ADMINISTRATOR MINIMUM REQUIREMENTS

Competencies, Knowledge, Skills, and Abilities

         1.       Demonstrated ability to work independently and guide Customer
                  through operational improvement process.

         2.       Knowledge of Radiology workflow.

         3.       Knowledge of Radiology Department and Hospital employees,
                  roles and responsibilities.

         4.       Strong process orientation, problem solving and
                  troubleshooting skills, and a firm commitment to quality

         5.       Must have the ability to understand, relate, and build
                  confidence in customer.

         6.       Experience in DICOM protocol, general computer network
                  technology, high performance computing systems and archival
                  storage systems.

         7.       Excellent verbal and written communication skills- ability to
                  interface and influence at multiple organizational levels.

Preferred Education and Experience

         1.       BS degree in technical discipline preferred.

         2.       5+ years in hospital information technology.

         3.       Licensed Radiology Technologist (R.T.) preferred.

         4.       Minimum 2 to 3 years project management experience working
                  with customers, vendors and leading cross-functional teams.

Emageon Enterprise Agreement           Page 47                      Confidential

<PAGE>

                                    EXHIBIT I
                                 ORDER ADDENDUM

                                EMAGEON UV, INC.
                                 ORDER ADDENDUM
                                       FOR

            This EMAGEON UV, INC., Order Addendum (the "ADDENDUM"), effective as
of _____________________ ("Effective Date") and entered into by and between
Emageon UV, Inc. ("Emageon"), whose principal place of business is at 1200
Corporate Drive, Suite 400, Birmingham, Alabama 35242, ________________, whose
principal place of business is at __________________________________ ("ASCENSION
MINISTRY"), and Ascension Health, whose principal place of business is at 4600
Edmundson Road, St. Louis MO. 63134 ("ASCENSION HEALTH" OR "CUSTOMER") shall
supplement and amend, where indicated, the EMAGEON UV, INC., MASTER TERMS AND
CONDITIONS, ENTERPRISE AGREEMENT (the "MASTER AGREEMENT") entered into by and
between EMAGEON UV, INC. ("Emageon"), and ASCENSION HEALTH dated
___________________, 2004. By way of clarification, in the event of conflict
between the terms of the Master Agreement and this Addendum, this Addendum shall
be controlling.

1.       The Master Agreement consists of the Enterprise Software Pricing for
         the Facilities and Affiliates as well as a description of the
         Implementation Service and the Maintenance and Support Services to be
         provided by Emageon. Ascension Ministry hereby agrees to accept the
         products and services set forth in the Master Agreement and in the
         following Attachments, and Emageon agrees to furnish such products and
         services, upon the terms and conditions of the Master Agreement and
         this Supplement and its Attachments to the Facilities set forth in
         Attachment D.

            This Supplement includes the following attachments:
                    Attachment A:     Site Survey
                    Attachment B:     SYSTEM configuration
                    Attachment C:     Terms and Fees
                    Attachment D:     Facilities
                    Attachment E:     Technical Points of Contact
                    Attachment F:     Response Time Service Level Specifications

IN WITNESS WHEREOF, the parties have caused this Supplement to be executed by
their duly authorized representatives and made effective as of the Effective
Date.

ACCEPTED AND AGREED TO:                   ACCEPTED AND AGREED TO:

Emageon:                                  ______________________________:
EMAGEON UV, INC.                          ______________________________

By: _____________________________         By: __________________________________

Name: ___________________________         Name: ________________________________

Its: ____________________________         Its: _________________________________

                                          Ascension Health

                                          By: __________________________________

                                          Name: ________________________________

                                          Its: _________________________________

Emageon Enterprise Agreement           Page 48                      Confidential

<PAGE>

                                  ATTACHMENT A
                                   SITE SURVEY

Ascension Ministry agrees the attached Site Survey represents a list of all
image acquisition devices located at the Facilities and their respective volumes
and study sizes. Ascension Ministry agrees that such Site Survey represents all
image acquisition devices that shall be connected to the SYSTEM. Ascension
Ministry shall first notify Emageon prior to making any changes that would add
new image acquisition devices or change the acquisition parameters, which would
thereby increase volume and / or study sizes. Ascension Ministry acknowledges
that such changes could result in diminished SYSTEM performance or capacity
subject to adjustments as contemplated in Section 9.8 of the Master Agreement.
Additionally, such changes will likely result in additional charges to Ascension
Ministry including integration fees and additional hardware / storage costs
necessary to maintain SYSTEM performance.

* * *

-----------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 49                      Confidential

<PAGE>

                                  ATTACHMENT B
                              SYSTEM CONFIGURATION

The following components constitute the SYSTEM whether supplied by Emageon or
Ascension Ministry. Any components not specified in the table below that are
subsequently required or desired shall be Ascension Ministry's responsibility.

Where Emageon supplies components, Emageon reserves the right to substitute
components that provide equal or better capacity, performance, and reliability.
Emageon shall first notify Ascension Ministry prior to any substitutions.

Where Ascension Ministry supplies components, the components must meet or exceed
Emageon listed specifications. Ascension Ministry-supplied components must be
approved by Emageon prior to installation to ensure compatibility with Emageon
Software and Hardware components. Ascension Ministry is required to maintain
compatibility with Emageon Software and Hardware components. Emageon may charge
Ascension Ministry a certification charge for non-approved hardware and software
components.

Any SYSTEM support issues that are attributable to Ascension Ministry supplied
components may result in additional service fees to Ascension Ministry.

SYSTEM unavailability attributable to Ascension Ministry-supported components
shall not constitute SYSTEM downtime.

* * *

---------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 50                      Confidential

<PAGE>

                                  ATTACHMENT C
                                 TERMS AND FEES

FACILITY - PRICING SCHEDULE AND TERMS [THE FOLLOWING TABLE IS TO BE COMPLETED
FOR EACH FACILITY]

* * *

---------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 51                      Confidential

<PAGE>

                                  ATTACHMENT D
                                   FACILITIES

The following list represents the Facilities covered by this Order Addendum.

[INSERT LIST OF FACILITIES]

Emageon Enterprise Agreement           Page 52                      Confidential

<PAGE>

                                  ATTACHMENT E
                           TECHNICAL POINTS OF CONTACT

The following list represents the Technical Points of Contact for Ascension
Ministry. Ascension Ministry may amend this list upon notice to Emageon.

[INSERT LIST OF TECHNICAL POINTS OF CONTACT]

Emageon Enterprise Agreement           Page 53                      Confidential

<PAGE>

                                  ATTACHMENT F
                    RESPONSE TIME SERVICE LEVEL SPECIFICATION

The specific specifications for the Response Time Service Levels for the
Facilities represented by this Order Addendum are as follows:

[INSERT RESPONSE TIME PERIOD, DEMARCATION POINT FOR MEASUREMENT AND OTHER
RESTRICTIONS OR CONDITIONS FOR EACH FACILITY]

Emageon Enterprise Agreement           Page 54                      Confidential

<PAGE>

                                    EXHIBIT J
                           PROFESSIONAL SERVICES RATES

The Professional Services Rates listed below shall apply to those activities
requested by Customer that are beyond the scope of the Implementation Services
and Support Services as set forth in Exhibit B of each Order Addendum.
Professional Services fees are billed separately from the SYSTEM fees and shall
be set forth in a separate Statement of Work. Professional Services will be
provided to Customer at the Professional Services Rates.

PROFESSIONAL SERVICES HOURLY FEES

<TABLE>
<S>                                                   <C>
Service Representative (per hour)                     $  * * *
Application Specialist (per hour)                     $  * * *
Interface Programming (per hour)                      $  * * *
Systems Engineer   (per hour)                         $  * * *
Integration HL7/DICOM Consulting (per hour)           $  * * *
Senior Application Consultant (per hour)              $  * * *
Clinical Consultant (per hour)                        $  * * *
Senior Clinical Consultant (per hour)                 $  * * *

Migration Services (per TB)                           $  * * *
</TABLE>

* The above Professional Services Rates DO NOT include either Travel and Living
Costs.

---------------------
* * * CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION.

Emageon Enterprise Agreement           Page 55                      Confidential

<PAGE>

                                    EXHIBIT K
                      CLINICAL INFORMATION SYSTEMS VENDORS

         -        Cerner

         -        Eclipsys

         -        EPIC

         -        McKesson

         -        Meditech

         -        Siemens

Emageon Enterprise Agreement           Page 56                      Confidential

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]